Serotonin control of sleep-wake behavior
Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions predominantly to promote wakefulness (W) and to inhibit REM (rapid eye movement) sleep (REMS). Yet, under certain circumstances the neurotransmitter con...
Saved in:
| Published in | Sleep medicine reviews Vol. 15; no. 4; pp. 269 - 281 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.08.2011
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions predominantly to promote wakefulness (W) and to inhibit REM (rapid eye movement) sleep (REMS). Yet, under certain circumstances the neurotransmitter contributes to the increase in sleep propensity. Most of the serotonergic innervation of the cerebral cortex, amygdala, basal forebrain (BFB), thalamus, preoptic and hypothalamic areas, raphe nuclei, locus coeruleus and pontine reticular formation comes from the dorsal raphe nucleus (DRN). The 5-HT receptors can be classified into at least seven classes, designated 5-HT
1–7. The 5-HT
1A and 5-HT
1B receptor subtypes are linked to the inhibition of adenylate cyclase, and their activation evokes a membrane hyperpolarization. The actions of the 5-HT
2A, 5-HT
2B and 5-HT
2C receptor subtypes are mediated by the activation of phospholipase C, with a resulting depolarization of the host cell. The 5-HT
3 receptor directly activates a 5-HT-gated cation channel which leads to the depolarization of monoaminergic, aminoacidergic and cholinergic cells. The primary signal transduction pathway of 5-HT
6 and 5-HT
7 receptors is the stimulation of adenylate cyclase which results in the depolarization of the follower neurons. Mutant mice that do not express 5-HT
1A or 5-HT
1B receptor exhibit greater amounts of REMS than their wild-type counterparts, which could be related to the absence of a postsynaptic inhibitory effect on REM-on neurons of the laterodorsal and pedunculopontine tegmental nuclei (LDT/PPT). 5-HT
2A and 5-HT
2C receptor knock-out mice show a significant increase of W and a reduction of slow wave sleep (SWS) which has been ascribed to the increase of catecholaminergic neurotransmission involving mainly the noradrenergic and dopaminergic systems. Sleep variables have been characterized, in addition, in 5-HT
7 receptor knock-out mice; the mutants spend less time in REMS that their wild-type counterparts. Direct infusion of the 5-HT
1A receptor agonists 8-OH-DPAT and flesinoxan into the DRN significantly enhances REMS in the rat. In contrast, microinjection of the 5-HT
1B (CP-94253), 5-HT
2A/2C (DOI), 5-HT
3 (m-chlorophenylbiguanide) and 5-HT
7 (LP-44) receptor agonists into the DRN induces a significant reduction of REMS. Systemic injection of full agonists at postsynaptic 5-HT
1A (8-OH-DPAT, flesinoxan), 5-HT
1B (CGS 12066B, CP-94235), 5-HT
2C (RO 60-0175), 5-HT
2A/2C (DOI, DOM), 5-HT
3 (m-chlorophenylbiguanide) and 5-HT
7 (LP-211) receptors increases W and reduces SWS and REMS. Of note, systemic administration of the 5-HT
2A/2C receptor antagonists ritanserin, ketanserin, ICI-170,809 or sertindole at the beginning of the light period has been shown to induce a significant increase of SWS and a reduction of REMS in the rat. Wakefulness was also diminished in most of these studies. Similar effects have been described following the injection of the selective 5-HT
2A receptor antagonists volinanserin and pruvanserin and of the 5-HT
2A receptor inverse agonist nelotanserin in rodents. In addition, the effects of these compounds have been studied on the sleep electroencephalogram of subjects with normal sleep. Their administration was followed by an increase of SWS and, in most instances, a reduction of REMS. The administration of ritanserin to poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder caused a significant increase in SWS. The 5-HT
2A receptor inverse agonist APD-125 induced also an increase of SWS in patients with chronic primary insomnia. It is known that during the administration of benzodiazepine (BZD) hypnotics to patients with insomnia there is a further reduction of SWS and REMS, whereas both variables tend to remain decreased during the use of non-BZD derivatives (zolpidem, zopiclone, eszopiclone, zaleplon). Thus, the association of 5-HT
2A antagonists or 5-HT
2A inverse agonists with BZD and non-BZD hypnotics could be a valid alternative to normalize SWS in patients with primary or comorbid insomnia. |
|---|---|
| AbstractList | Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions predominantly to promote wakefulness (W) and to inhibit REM (rapid eye movement) sleep (REMS). Yet, under certain circumstances the neurotransmitter contributes to the increase in sleep propensity. Most of the serotonergic innervation of the cerebral cortex, amygdala, basal forebrain (BFB), thalamus, preoptic and hypothalamic areas, raphe nuclei, locus coeruleus and pontine reticular formation comes from the dorsal raphe nucleus (DRN). The 5-HT receptors can be classified into at least seven classes, designated 5-HT
1–7. The 5-HT
1A and 5-HT
1B receptor subtypes are linked to the inhibition of adenylate cyclase, and their activation evokes a membrane hyperpolarization. The actions of the 5-HT
2A, 5-HT
2B and 5-HT
2C receptor subtypes are mediated by the activation of phospholipase C, with a resulting depolarization of the host cell. The 5-HT
3 receptor directly activates a 5-HT-gated cation channel which leads to the depolarization of monoaminergic, aminoacidergic and cholinergic cells. The primary signal transduction pathway of 5-HT
6 and 5-HT
7 receptors is the stimulation of adenylate cyclase which results in the depolarization of the follower neurons. Mutant mice that do not express 5-HT
1A or 5-HT
1B receptor exhibit greater amounts of REMS than their wild-type counterparts, which could be related to the absence of a postsynaptic inhibitory effect on REM-on neurons of the laterodorsal and pedunculopontine tegmental nuclei (LDT/PPT). 5-HT
2A and 5-HT
2C receptor knock-out mice show a significant increase of W and a reduction of slow wave sleep (SWS) which has been ascribed to the increase of catecholaminergic neurotransmission involving mainly the noradrenergic and dopaminergic systems. Sleep variables have been characterized, in addition, in 5-HT
7 receptor knock-out mice; the mutants spend less time in REMS that their wild-type counterparts. Direct infusion of the 5-HT
1A receptor agonists 8-OH-DPAT and flesinoxan into the DRN significantly enhances REMS in the rat. In contrast, microinjection of the 5-HT
1B (CP-94253), 5-HT
2A/2C (DOI), 5-HT
3 (m-chlorophenylbiguanide) and 5-HT
7 (LP-44) receptor agonists into the DRN induces a significant reduction of REMS. Systemic injection of full agonists at postsynaptic 5-HT
1A (8-OH-DPAT, flesinoxan), 5-HT
1B (CGS 12066B, CP-94235), 5-HT
2C (RO 60-0175), 5-HT
2A/2C (DOI, DOM), 5-HT
3 (m-chlorophenylbiguanide) and 5-HT
7 (LP-211) receptors increases W and reduces SWS and REMS. Of note, systemic administration of the 5-HT
2A/2C receptor antagonists ritanserin, ketanserin, ICI-170,809 or sertindole at the beginning of the light period has been shown to induce a significant increase of SWS and a reduction of REMS in the rat. Wakefulness was also diminished in most of these studies. Similar effects have been described following the injection of the selective 5-HT
2A receptor antagonists volinanserin and pruvanserin and of the 5-HT
2A receptor inverse agonist nelotanserin in rodents. In addition, the effects of these compounds have been studied on the sleep electroencephalogram of subjects with normal sleep. Their administration was followed by an increase of SWS and, in most instances, a reduction of REMS. The administration of ritanserin to poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder caused a significant increase in SWS. The 5-HT
2A receptor inverse agonist APD-125 induced also an increase of SWS in patients with chronic primary insomnia. It is known that during the administration of benzodiazepine (BZD) hypnotics to patients with insomnia there is a further reduction of SWS and REMS, whereas both variables tend to remain decreased during the use of non-BZD derivatives (zolpidem, zopiclone, eszopiclone, zaleplon). Thus, the association of 5-HT
2A antagonists or 5-HT
2A inverse agonists with BZD and non-BZD hypnotics could be a valid alternative to normalize SWS in patients with primary or comorbid insomnia. Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions predominantly to promote wakefulness (W) and to inhibit REM (rapid eye movement) sleep (REMS). Yet, under certain circumstances the neurotransmitter contributes to the increase in sleep propensity. Most of the serotonergic innervation of the cerebral cortex, amygdala, basal forebrain (BFB), thalamus, preoptic and hypothalamic areas, raphe nuclei, locus coeruleus and pontine reticular formation comes from the dorsal raphe nucleus (DRN). The 5-HT receptors can be classified into at least seven classes, designated 5-HT(1-7). The 5-HT(1A) and 5-HT(1B) receptor subtypes are linked to the inhibition of adenylate cyclase, and their activation evokes a membrane hyperpolarization. The actions of the 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptor subtypes are mediated by the activation of phospholipase C, with a resulting depolarization of the host cell. The 5-HT(3) receptor directly activates a 5-HT-gated cation channel which leads to the depolarization of monoaminergic, aminoacidergic and cholinergic cells. The primary signal transduction pathway of 5-HT(6) and 5-HT(7) receptors is the stimulation of adenylate cyclase which results in the depolarization of the follower neurons. Mutant mice that do not express 5-HT(1A) or 5-HT(1B) receptor exhibit greater amounts of REMS than their wild-type counterparts, which could be related to the absence of a postsynaptic inhibitory effect on REM-on neurons of the laterodorsal and pedunculopontine tegmental nuclei (LDT/PPT). 5-HT(2A) and 5-HT(2C) receptor knock-out mice show a significant increase of W and a reduction of slow wave sleep (SWS) which has been ascribed to the increase of catecholaminergic neurotransmission involving mainly the noradrenergic and dopaminergic systems. Sleep variables have been characterized, in addition, in 5-HT(7) receptor knock-out mice; the mutants spend less time in REMS that their wild-type counterparts. Direct infusion of the 5-HT(1A) receptor agonists 8-OH-DPAT and flesinoxan into the DRN significantly enhances REMS in the rat. In contrast, microinjection of the 5-HT(1B) (CP-94253), 5-HT(2A/2C) (DOI), 5-HT(3) (m-chlorophenylbiguanide) and 5-HT(7) (LP-44) receptor agonists into the DRN induces a significant reduction of REMS. Systemic injection of full agonists at postsynaptic 5-HT(1A) (8-OH-DPAT, flesinoxan), 5-HT(1B) (CGS 12066B, CP-94235), 5-HT(2C) (RO 60-0175), 5-HT(2A/2C) (DOI, DOM), 5-HT(3) (m-chlorophenylbiguanide) and 5-HT(7) (LP-211) receptors increases W and reduces SWS and REMS. Of note, systemic administration of the 5-HT(2A/2C) receptor antagonists ritanserin, ketanserin, ICI-170,809 or sertindole at the beginning of the light period has been shown to induce a significant increase of SWS and a reduction of REMS in the rat. Wakefulness was also diminished in most of these studies. Similar effects have been described following the injection of the selective 5-HT(2A) receptor antagonists volinanserin and pruvanserin and of the 5-HT(2A) receptor inverse agonist nelotanserin in rodents. In addition, the effects of these compounds have been studied on the sleep electroencephalogram of subjects with normal sleep. Their administration was followed by an increase of SWS and, in most instances, a reduction of REMS. The administration of ritanserin to poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder caused a significant increase in SWS. The 5-HT(2A) receptor inverse agonist APD-125 induced also an increase of SWS in patients with chronic primary insomnia. It is known that during the administration of benzodiazepine (BZD) hypnotics to patients with insomnia there is a further reduction of SWS and REMS, whereas both variables tend to remain decreased during the use of non-BZD derivatives (zolpidem, zopiclone, eszopiclone, zaleplon). Thus, the association of 5-HT(2A) antagonists or 5-HT(2A) inverse agonists with BZD and non-BZD hypnotics could be a valid alternative to normalize SWS in patients with primary or comorbid insomnia. Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions predominantly to promote wakefulness (W) and to inhibit REM (rapid eye movement) sleep (REMS). Yet, under certain circumstances the neurotransmitter contributes to the increase in sleep propensity. Most of the serotonergic innervation of the cerebral cortex, amygdala, basal forebrain (BFB), thalamus, preoptic and hypothalamic areas, raphe nuclei, locus coeruleus and pontine reticular formation comes from the dorsal raphe nucleus (DRN). The 5-HT receptors can be classified into at least seven classes, designated 5-HT(1-7). The 5-HT(1A) and 5-HT(1B) receptor subtypes are linked to the inhibition of adenylate cyclase, and their activation evokes a membrane hyperpolarization. The actions of the 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptor subtypes are mediated by the activation of phospholipase C, with a resulting depolarization of the host cell. The 5-HT(3) receptor directly activates a 5-HT-gated cation channel which leads to the depolarization of monoaminergic, aminoacidergic and cholinergic cells. The primary signal transduction pathway of 5-HT(6) and 5-HT(7) receptors is the stimulation of adenylate cyclase which results in the depolarization of the follower neurons. Mutant mice that do not express 5-HT(1A) or 5-HT(1B) receptor exhibit greater amounts of REMS than their wild-type counterparts, which could be related to the absence of a postsynaptic inhibitory effect on REM-on neurons of the laterodorsal and pedunculopontine tegmental nuclei (LDT/PPT). 5-HT(2A) and 5-HT(2C) receptor knock-out mice show a significant increase of W and a reduction of slow wave sleep (SWS) which has been ascribed to the increase of catecholaminergic neurotransmission involving mainly the noradrenergic and dopaminergic systems. Sleep variables have been characterized, in addition, in 5-HT(7) receptor knock-out mice; the mutants spend less time in REMS that their wild-type counterparts. Direct infusion of the 5-HT(1A) receptor agonists 8-OH-DPAT and flesinoxan into the DRN significantly enhances REMS in the rat. In contrast, microinjection of the 5-HT(1B) (CP-94253), 5-HT(2A/2C) (DOI), 5-HT(3) (m-chlorophenylbiguanide) and 5-HT(7) (LP-44) receptor agonists into the DRN induces a significant reduction of REMS. Systemic injection of full agonists at postsynaptic 5-HT(1A) (8-OH-DPAT, flesinoxan), 5-HT(1B) (CGS 12066B, CP-94235), 5-HT(2C) (RO 60-0175), 5-HT(2A/2C) (DOI, DOM), 5-HT(3) (m-chlorophenylbiguanide) and 5-HT(7) (LP-211) receptors increases W and reduces SWS and REMS. Of note, systemic administration of the 5-HT(2A/2C) receptor antagonists ritanserin, ketanserin, ICI-170,809 or sertindole at the beginning of the light period has been shown to induce a significant increase of SWS and a reduction of REMS in the rat. Wakefulness was also diminished in most of these studies. Similar effects have been described following the injection of the selective 5-HT(2A) receptor antagonists volinanserin and pruvanserin and of the 5-HT(2A) receptor inverse agonist nelotanserin in rodents. In addition, the effects of these compounds have been studied on the sleep electroencephalogram of subjects with normal sleep. Their administration was followed by an increase of SWS and, in most instances, a reduction of REMS. The administration of ritanserin to poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder caused a significant increase in SWS. The 5-HT(2A) receptor inverse agonist APD-125 induced also an increase of SWS in patients with chronic primary insomnia. It is known that during the administration of benzodiazepine (BZD) hypnotics to patients with insomnia there is a further reduction of SWS and REMS, whereas both variables tend to remain decreased during the use of non-BZD derivatives (zolpidem, zopiclone, eszopiclone, zaleplon). Thus, the association of 5-HT(2A) antagonists or 5-HT(2A) inverse agonists with BZD and non-BZD hypnotics could be a valid alternative to normalize SWS in patients with primary or comorbid insomnia.Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions predominantly to promote wakefulness (W) and to inhibit REM (rapid eye movement) sleep (REMS). Yet, under certain circumstances the neurotransmitter contributes to the increase in sleep propensity. Most of the serotonergic innervation of the cerebral cortex, amygdala, basal forebrain (BFB), thalamus, preoptic and hypothalamic areas, raphe nuclei, locus coeruleus and pontine reticular formation comes from the dorsal raphe nucleus (DRN). The 5-HT receptors can be classified into at least seven classes, designated 5-HT(1-7). The 5-HT(1A) and 5-HT(1B) receptor subtypes are linked to the inhibition of adenylate cyclase, and their activation evokes a membrane hyperpolarization. The actions of the 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptor subtypes are mediated by the activation of phospholipase C, with a resulting depolarization of the host cell. The 5-HT(3) receptor directly activates a 5-HT-gated cation channel which leads to the depolarization of monoaminergic, aminoacidergic and cholinergic cells. The primary signal transduction pathway of 5-HT(6) and 5-HT(7) receptors is the stimulation of adenylate cyclase which results in the depolarization of the follower neurons. Mutant mice that do not express 5-HT(1A) or 5-HT(1B) receptor exhibit greater amounts of REMS than their wild-type counterparts, which could be related to the absence of a postsynaptic inhibitory effect on REM-on neurons of the laterodorsal and pedunculopontine tegmental nuclei (LDT/PPT). 5-HT(2A) and 5-HT(2C) receptor knock-out mice show a significant increase of W and a reduction of slow wave sleep (SWS) which has been ascribed to the increase of catecholaminergic neurotransmission involving mainly the noradrenergic and dopaminergic systems. Sleep variables have been characterized, in addition, in 5-HT(7) receptor knock-out mice; the mutants spend less time in REMS that their wild-type counterparts. Direct infusion of the 5-HT(1A) receptor agonists 8-OH-DPAT and flesinoxan into the DRN significantly enhances REMS in the rat. In contrast, microinjection of the 5-HT(1B) (CP-94253), 5-HT(2A/2C) (DOI), 5-HT(3) (m-chlorophenylbiguanide) and 5-HT(7) (LP-44) receptor agonists into the DRN induces a significant reduction of REMS. Systemic injection of full agonists at postsynaptic 5-HT(1A) (8-OH-DPAT, flesinoxan), 5-HT(1B) (CGS 12066B, CP-94235), 5-HT(2C) (RO 60-0175), 5-HT(2A/2C) (DOI, DOM), 5-HT(3) (m-chlorophenylbiguanide) and 5-HT(7) (LP-211) receptors increases W and reduces SWS and REMS. Of note, systemic administration of the 5-HT(2A/2C) receptor antagonists ritanserin, ketanserin, ICI-170,809 or sertindole at the beginning of the light period has been shown to induce a significant increase of SWS and a reduction of REMS in the rat. Wakefulness was also diminished in most of these studies. Similar effects have been described following the injection of the selective 5-HT(2A) receptor antagonists volinanserin and pruvanserin and of the 5-HT(2A) receptor inverse agonist nelotanserin in rodents. In addition, the effects of these compounds have been studied on the sleep electroencephalogram of subjects with normal sleep. Their administration was followed by an increase of SWS and, in most instances, a reduction of REMS. The administration of ritanserin to poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder caused a significant increase in SWS. The 5-HT(2A) receptor inverse agonist APD-125 induced also an increase of SWS in patients with chronic primary insomnia. It is known that during the administration of benzodiazepine (BZD) hypnotics to patients with insomnia there is a further reduction of SWS and REMS, whereas both variables tend to remain decreased during the use of non-BZD derivatives (zolpidem, zopiclone, eszopiclone, zaleplon). Thus, the association of 5-HT(2A) antagonists or 5-HT(2A) inverse agonists with BZD and non-BZD hypnotics could be a valid alternative to normalize SWS in patients with primary or comorbid insomnia. Summary Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions predominantly to promote wakefulness (W) and to inhibit REM (rapid eye movement) sleep (REMS). Yet, under certain circumstances the neurotransmitter contributes to the increase in sleep propensity. Most of the serotonergic innervation of the cerebral cortex, amygdala, basal forebrain (BFB), thalamus, preoptic and hypothalamic areas, raphe nuclei, locus coeruleus and pontine reticular formation comes from the dorsal raphe nucleus (DRN). The 5-HT receptors can be classified into at least seven classes, designated 5-HT1–7 . The 5-HT1A and 5-HT1B receptor subtypes are linked to the inhibition of adenylate cyclase, and their activation evokes a membrane hyperpolarization. The actions of the 5-HT2A , 5-HT2B and 5-HT2C receptor subtypes are mediated by the activation of phospholipase C, with a resulting depolarization of the host cell. The 5-HT3 receptor directly activates a 5-HT-gated cation channel which leads to the depolarization of monoaminergic, aminoacidergic and cholinergic cells. The primary signal transduction pathway of 5-HT6 and 5-HT7 receptors is the stimulation of adenylate cyclase which results in the depolarization of the follower neurons. Mutant mice that do not express 5-HT1A or 5-HT1B receptor exhibit greater amounts of REMS than their wild-type counterparts, which could be related to the absence of a postsynaptic inhibitory effect on REM-on neurons of the laterodorsal and pedunculopontine tegmental nuclei (LDT/PPT). 5-HT2A and 5-HT2C receptor knock-out mice show a significant increase of W and a reduction of slow wave sleep (SWS) which has been ascribed to the increase of catecholaminergic neurotransmission involving mainly the noradrenergic and dopaminergic systems. Sleep variables have been characterized, in addition, in 5-HT7 receptor knock-out mice; the mutants spend less time in REMS that their wild-type counterparts. Direct infusion of the 5-HT1A receptor agonists 8-OH-DPAT and flesinoxan into the DRN significantly enhances REMS in the rat. In contrast, microinjection of the 5-HT1B (CP-94253), 5-HT2A/2C (DOI), 5-HT3 (m-chlorophenylbiguanide) and 5-HT7 (LP-44) receptor agonists into the DRN induces a significant reduction of REMS. Systemic injection of full agonists at postsynaptic 5-HT1A (8-OH-DPAT, flesinoxan), 5-HT1B (CGS 12066B, CP-94235), 5-HT2C (RO 60-0175), 5-HT2A/2C (DOI, DOM), 5-HT3 (m-chlorophenylbiguanide) and 5-HT7 (LP-211) receptors increases W and reduces SWS and REMS. Of note, systemic administration of the 5-HT2A/2C receptor antagonists ritanserin, ketanserin, ICI-170,809 or sertindole at the beginning of the light period has been shown to induce a significant increase of SWS and a reduction of REMS in the rat. Wakefulness was also diminished in most of these studies. Similar effects have been described following the injection of the selective 5-HT2A receptor antagonists volinanserin and pruvanserin and of the 5-HT2A receptor inverse agonist nelotanserin in rodents. In addition, the effects of these compounds have been studied on the sleep electroencephalogram of subjects with normal sleep. Their administration was followed by an increase of SWS and, in most instances, a reduction of REMS. The administration of ritanserin to poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder caused a significant increase in SWS. The 5-HT2A receptor inverse agonist APD-125 induced also an increase of SWS in patients with chronic primary insomnia. It is known that during the administration of benzodiazepine (BZD) hypnotics to patients with insomnia there is a further reduction of SWS and REMS, whereas both variables tend to remain decreased during the use of non-BZD derivatives (zolpidem, zopiclone, eszopiclone, zaleplon). Thus, the association of 5-HT2A antagonists or 5-HT2A inverse agonists with BZD and non-BZD hypnotics could be a valid alternative to normalize SWS in patients with primary or comorbid insomnia. |
| Author | Monti, Jaime M. |
| Author_xml | – sequence: 1 givenname: Jaime M. surname: Monti fullname: Monti, Jaime M. email: jmonti@mednet.org.uy organization: Department of Pharmacology and Therapeutics, School of Medicine Clinics Hospital, Montevideo 11600, Uruguay |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21459634$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUFP4zAQha0VaGkLf4AD6m33kmJPEjdGK6RVBbtISByA88hxJsIltYuddsW_X4fCBQk42bLeN5733pjtOe-IsWPBZ4ILebqcxVXYzoAPD2LGef6NjUSZQwaqLPfSnVfzjM8VHLBxjEvOuSqE_M4OQBSlknkxYj9vKfjeO-umxrs--G7q22nsiNbZP_1I05oe9Nb6cMj2W91FOno9J-z-8uJu8Te7vvlztfh9nZlCij6jRhMYgLpuFZVgaE4N5A3nVZ0baKtaVhWoqi6NaintSpwLJVtNVErVSson7Mdu7jr4pw3FHlc2Guo67chvIlZzKKFQEpLy5FW5qVfU4DrYlQ7P-GYuCaqdwAQfY6AWje11bwef2nYoOA454hKHHHHIEYXAlGNC4R36Nv1T6NcOopTP1lLAaCw5Q40NZHpsvP0cP3-Hm846a3T3SM8Ul34TXEoeBUZAjrdDu0O5IvUq8he_Zx8P-Or3_y0ns98 |
| CitedBy_id | crossref_primary_10_1111_jsr_12248 crossref_primary_10_1016_j_ijchp_2023_100405 crossref_primary_10_1186_s40580_022_00325_7 crossref_primary_10_1016_j_reprotox_2017_05_003 crossref_primary_10_3389_dyst_2022_10691 crossref_primary_10_1080_0972060X_2023_2187262 crossref_primary_10_1080_0886022X_2023_2190815 crossref_primary_10_1002_hbm_70119 crossref_primary_10_1016_j_sleep_2011_12_006 crossref_primary_10_1016_j_jneumeth_2024_110158 crossref_primary_10_1016_j_fitote_2024_106205 crossref_primary_10_3389_fnana_2017_00130 crossref_primary_10_14401_KASMED_2016_23_1_5 crossref_primary_10_14411_fp_2025_002 crossref_primary_10_3390_ijms20102370 crossref_primary_10_3390_cimb46100663 crossref_primary_10_5665_sleep_1876 crossref_primary_10_1016_j_cej_2021_132633 crossref_primary_10_7143_jhep_2020_12 crossref_primary_10_2174_1570161117666190506111239 crossref_primary_10_1016_j_apsb_2024_01_015 crossref_primary_10_1111_nan_12024 crossref_primary_10_1016_j_jsmc_2022_03_002 crossref_primary_10_1016_j_neubiorev_2019_01_013 crossref_primary_10_1016_j_smrv_2013_02_004 crossref_primary_10_1007_s12035_023_03519_0 crossref_primary_10_1517_14728214_2012_690735 crossref_primary_10_26599_SAB_2023_9060007 crossref_primary_10_1146_annurev_neuro_080317_061813 crossref_primary_10_1007_s11055_019_00887_w crossref_primary_10_1007_s40263_016_0352_5 crossref_primary_10_1248_bpb_b14_00887 crossref_primary_10_1016_j_jchemneu_2017_04_001 crossref_primary_10_5665_sleep_2972 crossref_primary_10_1152_jn_00064_2016 crossref_primary_10_1016_j_ijdevneu_2013_01_006 crossref_primary_10_1038_s41598_021_03753_3 crossref_primary_10_3390_pr10081609 crossref_primary_10_1093_nsr_nwad309 crossref_primary_10_1007_s12035_024_04400_4 crossref_primary_10_1007_s12031_014_0272_0 crossref_primary_10_1073_pnas_1402663111 crossref_primary_10_1016_j_neuroimage_2013_06_021 crossref_primary_10_1021_acschemneuro_4c00667 crossref_primary_10_1515_revneuro_2014_0016 crossref_primary_10_3390_nu13082845 crossref_primary_10_1007_s00401_020_02206_x crossref_primary_10_1186_s12866_021_02361_5 crossref_primary_10_3390_biology10090923 crossref_primary_10_1080_14656566_2019_1674283 crossref_primary_10_1113_JP282509 crossref_primary_10_3390_jcm8122133 crossref_primary_10_1007_s41782_021_00179_9 crossref_primary_10_1016_j_biopha_2024_116937 crossref_primary_10_1093_sleep_zsae080 crossref_primary_10_1146_annurev_pharmtox_010715_103801 crossref_primary_10_1016_j_neuron_2019_05_038 crossref_primary_10_3389_fphar_2023_1210393 crossref_primary_10_3390_ph17091161 crossref_primary_10_1007_s13167_011_0101_2 crossref_primary_10_1016_j_bmcl_2023_129461 crossref_primary_10_1111_jsr_13547 crossref_primary_10_1007_s12576_013_0296_1 crossref_primary_10_1016_j_brainresbull_2021_12_016 crossref_primary_10_1186_s40064_014_0777_6 crossref_primary_10_1152_japplphysiol_00376_2020 crossref_primary_10_1016_j_pbb_2012_05_012 crossref_primary_10_3389_fnmol_2023_1102808 crossref_primary_10_3389_fpsyt_2018_00320 crossref_primary_10_3390_nu13010248 crossref_primary_10_3390_foods14071080 crossref_primary_10_1055_s_0044_1801292 crossref_primary_10_1080_1028415X_2024_2303217 crossref_primary_10_1097_FBP_0000000000000142 crossref_primary_10_1016_j_bcp_2024_116554 crossref_primary_10_1111_acps_12784 crossref_primary_10_1523_ENEURO_0116_17_2017 crossref_primary_10_1002_bies_202300213 crossref_primary_10_3724_SP_J_1041_2022_00604 crossref_primary_10_3390_jcm7050102 crossref_primary_10_3390_brainsci10070441 crossref_primary_10_1007_s00213_021_05922_8 crossref_primary_10_1016_j_jep_2024_118907 crossref_primary_10_1111_jcpt_12563 crossref_primary_10_1371_journal_pone_0118603 crossref_primary_10_1016_S1875_5364_23_60405_4 crossref_primary_10_1016_j_bbr_2013_04_024 crossref_primary_10_1097_WNF_0000000000000307 crossref_primary_10_1007_s43440_021_00339_8 crossref_primary_10_1038_s41586_020_1993_6 crossref_primary_10_14348_molcells_2015_0258 crossref_primary_10_3389_fneur_2024_1406485 crossref_primary_10_1016_j_smrv_2023_101870 crossref_primary_10_1016_j_sleep_2015_09_021 crossref_primary_10_1016_j_nbscr_2016_09_002 crossref_primary_10_1186_s12889_024_19141_1 crossref_primary_10_1080_14656566_2024_2373350 crossref_primary_10_1002_fsn3_1050 crossref_primary_10_1016_j_jep_2025_119590 crossref_primary_10_3389_fnins_2018_00535 crossref_primary_10_3390_mi13030488 crossref_primary_10_1016_j_neuroscience_2011_09_024 crossref_primary_10_1371_journal_pone_0153346 crossref_primary_10_1007_s11356_022_19482_7 crossref_primary_10_3389_fncel_2021_614947 crossref_primary_10_1111_jnc_15576 crossref_primary_10_1186_2040_2392_4_37 crossref_primary_10_3389_fphar_2022_1009668 crossref_primary_10_1002_elsa_202000024 crossref_primary_10_1038_s41598_024_79429_5 crossref_primary_10_1038_pr_2014_140 crossref_primary_10_12677_ASS_2023_123161 crossref_primary_10_3390_ijms21228776 crossref_primary_10_1016_j_comppsych_2021_152270 crossref_primary_10_1016_j_pnpbp_2025_111279 crossref_primary_10_1016_j_scitotenv_2024_174525 crossref_primary_10_1523_JNEUROSCI_4388_12_2013 crossref_primary_10_1021_cn300186b crossref_primary_10_3389_fncir_2014_00069 crossref_primary_10_1016_j_nbd_2024_106499 crossref_primary_10_3390_clockssleep4020024 crossref_primary_10_5498_wjp_v11_i11_954 crossref_primary_10_1016_j_jpeds_2018_01_036 crossref_primary_10_1016_j_biopha_2022_112688 crossref_primary_10_1124_pr_118_015552 crossref_primary_10_1016_j_sleep_2023_11_033 crossref_primary_10_1038_s41467_023_42945_5 crossref_primary_10_1134_S181971242301004X crossref_primary_10_1021_acschemneuro_6b00412 crossref_primary_10_1111_1750_3841_17634 crossref_primary_10_4103_hm_hm_51_19 crossref_primary_10_1016_j_prmcm_2024_100504 crossref_primary_10_3390_nu13051586 crossref_primary_10_1016_j_pharmthera_2019_107402 crossref_primary_10_1093_cercor_bhad001 crossref_primary_10_1177_09612033221140724 crossref_primary_10_1016_j_jad_2023_04_090 crossref_primary_10_1024_1661_8157_a003189 crossref_primary_10_3389_fneur_2018_00095 crossref_primary_10_1016_j_cogsys_2022_11_004 crossref_primary_10_1186_s12906_019_2732_0 crossref_primary_10_30569_adiyamansaglik_470317 crossref_primary_10_1007_s40675_025_00329_9 crossref_primary_10_1155_2015_354957 crossref_primary_10_14401_KASMED_2016_23_1_10 crossref_primary_10_1111_cns_13656 crossref_primary_10_1111_fcp_12949 crossref_primary_10_1111_ejn_13273 crossref_primary_10_1177_0269881116681399 crossref_primary_10_12771_emj_2013_36_2_84 crossref_primary_10_1016_j_bbr_2014_03_037 crossref_primary_10_1002_cne_23929 crossref_primary_10_1038_s41398_019_0416_7 crossref_primary_10_1002_jsfa_14173 crossref_primary_10_1016_j_psychres_2019_02_030 crossref_primary_10_1016_j_cbpc_2023_109813 crossref_primary_10_3389_fpsyt_2022_817302 crossref_primary_10_1007_s13311_017_0546_7 crossref_primary_10_1016_j_clinbiochem_2016_06_014 crossref_primary_10_3389_fneur_2021_716097 crossref_primary_10_1016_j_biocel_2024_106663 crossref_primary_10_1152_ajpregu_00400_2014 crossref_primary_10_1016_j_neuropharm_2024_110036 crossref_primary_10_1016_j_cub_2019_08_079 crossref_primary_10_1016_j_neuropharm_2015_06_015 crossref_primary_10_1016_j_neures_2016_07_004 crossref_primary_10_1177_0333102411436332 crossref_primary_10_1016_j_phrs_2016_04_028 crossref_primary_10_1007_s11064_024_04102_2 crossref_primary_10_1021_acs_jafc_4c01074 crossref_primary_10_3389_fphar_2020_602590 crossref_primary_10_1007_s00484_025_02855_1 crossref_primary_10_1016_j_pnpbp_2021_110449 crossref_primary_10_3389_fncir_2015_00063 crossref_primary_10_4137_JCNSD_S9381 crossref_primary_10_3233_THC_230506 crossref_primary_10_1159_000499503 crossref_primary_10_3389_fneur_2018_01069 crossref_primary_10_17116_jnevro2021121041158 crossref_primary_10_3389_fphar_2019_00053 crossref_primary_10_1016_j_smrv_2018_09_006 crossref_primary_10_3390_nu10101478 crossref_primary_10_1093_sleep_zsw046 crossref_primary_10_1016_j_neuroscience_2022_07_008 crossref_primary_10_1038_s41582_024_01052_9 crossref_primary_10_1113_jphysiol_2011_219469 crossref_primary_10_1002_cne_25529 crossref_primary_10_1007_s00221_022_06328_4 crossref_primary_10_1371_journal_pgen_1010289 crossref_primary_10_4109_jslab_33_186 crossref_primary_10_7554_eLife_26519 crossref_primary_10_1039_C9RA01549C crossref_primary_10_1016_j_nicl_2018_03_001 crossref_primary_10_1152_jn_00034_2020 crossref_primary_10_1002_mds_27461 crossref_primary_10_1007_s10597_016_0035_1 crossref_primary_10_1089_jwh_2023_0316 crossref_primary_10_1111_ajpy_12098 crossref_primary_10_1586_14737175_2016_1158102 crossref_primary_10_4062_biomolther_2016_156 crossref_primary_10_1124_mol_117_111229 crossref_primary_10_1038_s41598_024_70871_z crossref_primary_10_1007_s40120_021_00290_z crossref_primary_10_1016_j_neures_2017_07_005 crossref_primary_10_1016_j_jchemneu_2012_12_006 crossref_primary_10_1016_j_ypmed_2023_107682 crossref_primary_10_1017_S0007114522002896 crossref_primary_10_1016_j_smrv_2012_10_002 crossref_primary_10_1515_revneuro_2015_0013 crossref_primary_10_1016_j_heliyon_2024_e27976 crossref_primary_10_1212_WNL_0000000000013128 crossref_primary_10_1152_ajpregu_00241_2015 crossref_primary_10_1111_bph_12782 crossref_primary_10_1089_cap_2014_0169 crossref_primary_10_9758_cpn_2022_20_2_248 crossref_primary_10_3389_fnsys_2021_682990 crossref_primary_10_1002_mds_26484 crossref_primary_10_1016_j_expneurol_2022_113976 crossref_primary_10_1177_17540739221114109 crossref_primary_10_1007_s40675_015_0013_0 crossref_primary_10_1016_j_bbr_2013_11_030 crossref_primary_10_1021_cn300072u crossref_primary_10_1016_j_neubiorev_2014_10_021 crossref_primary_10_1177_0269881115592347 crossref_primary_10_1016_j_jep_2024_118401 crossref_primary_10_1016_j_smrv_2023_101892 crossref_primary_10_1016_j_jchemneu_2015_10_002 crossref_primary_10_5665_sleep_5256 crossref_primary_10_1007_s00213_015_3980_4 crossref_primary_10_1080_19490976_2022_2128605 crossref_primary_10_1016_j_smrv_2021_101449 crossref_primary_10_1016_j_drudis_2014_01_001 crossref_primary_10_1038_s41598_016_0018_z crossref_primary_10_1093_jnen_nlad030 crossref_primary_10_1111_inr_12963 crossref_primary_10_1002_cncr_33844 crossref_primary_10_1016_j_biopha_2021_112141 crossref_primary_10_1002_fsn3_3016 crossref_primary_10_1146_annurev_pharmtox_040323_031929 crossref_primary_10_3390_clockssleep4010014 crossref_primary_10_1007_s00439_017_1826_3 crossref_primary_10_1016_j_neubiorev_2019_07_019 crossref_primary_10_1152_jn_00213_2015 crossref_primary_10_3390_nu14245299 crossref_primary_10_1177_0333102414542662 crossref_primary_10_1002_hbm_26139 crossref_primary_10_1016_j_jep_2020_113627 crossref_primary_10_3390_ijms23031430 crossref_primary_10_1016_j_bbr_2025_115451 crossref_primary_10_1016_j_pnpbp_2015_05_005 crossref_primary_10_1016_j_tice_2014_06_005 crossref_primary_10_1038_s41598_019_56892_z crossref_primary_10_1177_07487304241302547 crossref_primary_10_1002_bdr2_1078 crossref_primary_10_1007_s10802_018_0480_0 crossref_primary_10_1111_jcpp_12812 crossref_primary_10_1016_j_smrv_2018_01_008 crossref_primary_10_1371_journal_pone_0230367 crossref_primary_10_1007_s11920_013_0389_9 crossref_primary_10_3390_biom12070898 crossref_primary_10_4196_kjpp_2021_25_5_449 crossref_primary_10_1007_s40675_015_0012_1 crossref_primary_10_3906_sag_1507_68 crossref_primary_10_1002_jms_3243 crossref_primary_10_1111_apha_12449 crossref_primary_10_1186_s40035_016_0056_2 crossref_primary_10_1016_j_jsmc_2018_03_002 crossref_primary_10_1371_journal_pone_0054250 crossref_primary_10_1038_s41589_022_01148_7 crossref_primary_10_1016_j_virol_2017_01_007 crossref_primary_10_1021_acs_jmedchem_0c01560 crossref_primary_10_1371_journal_pbio_2002612 crossref_primary_10_3389_fneur_2022_998103 crossref_primary_10_3389_fnins_2023_1179765 crossref_primary_10_3389_fphar_2019_01636 crossref_primary_10_1523_JNEUROSCI_2603_12_2013 crossref_primary_10_1016_j_pharmthera_2015_11_009 crossref_primary_10_1016_j_euroneuro_2014_01_015 crossref_primary_10_1016_j_jep_2024_118942 crossref_primary_10_1016_j_neurot_2024_e00374 crossref_primary_10_1093_intimm_dxae035 crossref_primary_10_3390_analytica3020013 crossref_primary_10_3389_fnhum_2016_00571 crossref_primary_10_17116_jnevro202012009255 crossref_primary_10_1016_j_psychres_2024_115764 crossref_primary_10_1186_s13024_023_00617_4 crossref_primary_10_3389_fnins_2024_1346635 crossref_primary_10_1016_j_biopha_2018_10_003 crossref_primary_10_1016_j_smrv_2015_08_003 crossref_primary_10_1016_j_tox_2015_08_004 crossref_primary_10_1007_s12035_011_8214_0 crossref_primary_10_1111_cns_12260 crossref_primary_10_18705_1607_419X_2019_25_2_143_157 crossref_primary_10_3389_fnins_2018_00498 crossref_primary_10_3109_13697137_2015_1042450 crossref_primary_10_1016_j_brainresbull_2021_09_019 crossref_primary_10_2147_NSS_S272883 crossref_primary_10_1016_j_brainresbull_2019_12_006 crossref_primary_10_3389_fmicb_2022_1028913 crossref_primary_10_1093_sleep_zsab012 crossref_primary_10_1162_netn_a_00119 crossref_primary_10_18231_j_ijcap_2023_029 crossref_primary_10_1007_s00415_024_12692_8 crossref_primary_10_1007_s00213_023_06442_3 crossref_primary_10_1016_j_neuropharm_2016_05_015 crossref_primary_10_5665_sleep_5000 crossref_primary_10_1186_s13041_016_0252_0 crossref_primary_10_26599_FSHW_2022_9250162 crossref_primary_10_1016_j_yebeh_2013_07_025 crossref_primary_10_1038_s41386_019_0439_z crossref_primary_10_1152_physiol_00043_2020 crossref_primary_10_1517_13543784_2015_987340 crossref_primary_10_3390_ijms252413446 crossref_primary_10_1016_j_domaniend_2018_03_001 crossref_primary_10_1093_geroni_igae072 crossref_primary_10_1002_imo2_60 crossref_primary_10_1016_j_cbpb_2023_110930 crossref_primary_10_1177_0004867415579920 crossref_primary_10_1038_s41386_019_0465_x crossref_primary_10_1016_j_bbr_2021_113440 crossref_primary_10_1016_j_jfma_2021_10_013 crossref_primary_10_3390_ijms22073537 crossref_primary_10_3390_molecules27113417 crossref_primary_10_18632_oncotarget_13419 crossref_primary_10_2147_NSS_S349511 crossref_primary_10_3390_nu15245037 crossref_primary_10_1016_j_psyneuen_2014_09_022 crossref_primary_10_1016_j_ebiom_2015_10_020 crossref_primary_10_3390_jpm14050519 crossref_primary_10_1111_cns_70141 crossref_primary_10_1186_s12868_019_0495_7 crossref_primary_10_1146_annurev_nutr_120420_021719 crossref_primary_10_1134_S0362119722020098 crossref_primary_10_1016_j_pneurobio_2016_04_001 crossref_primary_10_1073_pnas_1614552114 crossref_primary_10_1016_j_brainresbull_2020_08_025 crossref_primary_10_1038_s41398_024_02816_z crossref_primary_10_12965_jer_2550048_024 crossref_primary_10_1007_s00213_013_3046_4 crossref_primary_10_1016_j_neuroscience_2022_06_023 crossref_primary_10_3390_antiox13060657 crossref_primary_10_1016_j_biopha_2022_112983 crossref_primary_10_1128_JVI_02252_13 crossref_primary_10_3389_fpsyt_2022_777566 crossref_primary_10_1016_S0001_4079_19_31955_7 crossref_primary_10_1002_ajmg_b_33021 crossref_primary_10_1038_srep14843 crossref_primary_10_1254_fpj_150_177 crossref_primary_10_1177_0269881120959609 crossref_primary_10_1016_j_jad_2019_07_042 crossref_primary_10_1038_s41398_022_01846_9 crossref_primary_10_3390_ijms21051649 crossref_primary_10_1093_sleep_zsaa085 crossref_primary_10_1152_japplphysiol_00724_2018 crossref_primary_10_1186_s12888_025_06664_z crossref_primary_10_1111_andr_13168 crossref_primary_10_1177_0269881113490326 crossref_primary_10_1186_s12889_023_16836_9 crossref_primary_10_1007_s00429_024_02878_1 crossref_primary_10_1016_j_biopsych_2023_12_023 crossref_primary_10_1016_j_numecd_2019_09_019 crossref_primary_10_1016_j_sleep_2025_01_007 crossref_primary_10_1016_j_fbio_2024_105345 crossref_primary_10_1038_s41598_021_83389_5 crossref_primary_10_1016_j_pneurobio_2016_09_003 crossref_primary_10_1007_s00221_015_4344_3 crossref_primary_10_1177_0269881119856546 crossref_primary_10_1177_15598276241262234 crossref_primary_10_1016_j_nbscr_2021_100072 crossref_primary_10_1177_09731296241264616 crossref_primary_10_1007_s10578_015_0557_8 crossref_primary_10_1007_s00380_020_01769_9 crossref_primary_10_1038_npp_2016_280 crossref_primary_10_1016_j_mehy_2014_04_026 crossref_primary_10_1523_JNEUROSCI_0635_16_2016 crossref_primary_10_1080_14737175_2023_2267761 crossref_primary_10_1007_s00213_013_3122_9 crossref_primary_10_1016_j_neubiorev_2022_104653 crossref_primary_10_1155_2022_7425538 |
| Cites_doi | 10.1016/j.pnpbp.2006.02.013 10.1007/BF02244239 10.1002/syn.10288 10.1007/BF00439544 10.1016/j.neulet.2004.04.080 10.1523/JNEUROSCI.22-11-04686.2002 10.1093/sleep/31.1.34 10.1016/0006-8993(76)90480-7 10.1016/j.biopsych.2005.05.012 10.1016/S0006-8993(00)03004-3 10.1016/0028-3908(94)90077-9 10.1002/cne.903300410 10.1016/0091-3057(94)00394-X 10.1017/S1461145704004511 10.1016/j.neuroscience.2004.06.037 10.1523/JNEUROSCI.16-08-02820.1996 10.1016/j.bbr.2010.08.020 10.1016/j.brainres.2009.02.010 10.1002/syn.20054 10.1007/BF00401382 10.1016/S0361-9230(97)00340-7 10.1046/j.1460-9568.2003.02836.x 10.1016/S0006-8993(02)02360-0 10.1111/j.1365-2869.1992.tb00033.x 10.1126/science.166.3911.1433 10.1016/S0306-4522(01)00103-8 10.1007/BF00442811 10.1176/ajp.148.9.1213 10.1523/JNEUROSCI.21-24-09856.2001 10.1111/j.1471-4159.2005.03485.x 10.1007/BF00419813 10.1111/j.1600-0447.1992.tb03241.x 10.1093/sleep/16.7.647 10.1016/j.neuroscience.2009.11.071 10.1002/(SICI)1096-9861(19981221)402:3<385::AID-CNE7>3.0.CO;2-Q 10.1016/0006-8993(79)90157-4 10.1111/j.1460-9568.1993.tb00519.x 10.1002/syn.890100402 10.1016/S0306-4522(03)00518-9 10.1159/000026676 10.1016/0006-8993(93)90077-Z 10.1016/S0924-977X(01)00133-X 10.2174/1568007043482561 10.1517/14656560802532707 10.1007/BF02244783 10.1016/S0028-3908(99)00086-6 10.1002/cne.10976 10.1016/0306-4522(91)90128-B 10.1093/sleep/5.2.145 10.1111/j.1460-9568.2007.05796.x 10.1016/S0306-4522(99)00435-2 10.1016/j.ejphar.2003.08.039 10.1523/JNEUROSCI.1724-05.2005 10.1002/(SICI)1096-9861(19970609)382:3<302::AID-CNE2>3.0.CO;2-7 10.1016/S0006-8993(02)03841-6 10.1016/0028-3908(95)00112-3 10.1016/0006-8993(91)90242-N 10.1016/0006-8993(83)90011-2 10.1111/j.1460-9568.2006.05222.x 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P 10.1016/S0893-133X(02)00353-6 10.1016/S0006-8993(01)02101-1 10.1152/physrev.1992.72.1.165 10.1016/0306-4522(93)90262-E 10.1007/BF02245128 10.1002/(SICI)1097-4547(19961215)46:6<697::AID-JNR7>3.0.CO;2-A 10.1016/0014-2999(95)00108-W 10.1016/S0006-8993(02)02475-7 10.1124/pr.59.07103 10.1016/S0301-0082(98)00084-7 10.1016/j.brainres.2003.09.026 10.1111/j.1476-5381.1996.tb15241.x 10.1016/0006-8993(76)90975-6 10.1002/cne.20138 10.1111/j.1476-5381.1995.tb14977.x 10.1080/15622970802465807 10.1016/S0022-3565(24)37669-4 10.1016/0006-8993(86)90299-4 10.1037/a0018244 10.1016/S0306-4522(98)00256-5 10.1124/jpet.105.086413 10.1016/j.neuroscience.2009.09.028 10.3109/00207459808986431 10.1152/ajpregu.00074.2005 10.1124/jpet.109.160994 10.1038/sj.bjp.0703288 10.1016/0014-2999(91)90499-G 10.1007/BF02247474 10.1016/0091-3057(94)90461-8 10.1007/BF00432724 10.1097/00001756-199802160-00033 10.1016/S0014-2999(98)00826-7 10.1007/BF00216069 10.1038/sj.bjp.0705887 10.1016/0014-2999(68)90151-9 10.1016/j.sleep.2007.03.013 10.1358/mf.2004.26.8.863726 10.1016/0028-3908(95)00138-7 10.1016/j.pnpbp.2009.05.013 10.1016/0306-4522(90)90267-8 10.1016/j.bbr.2008.03.025 10.1523/JNEUROSCI.19-08-03204.1999 10.1006/bbrc.1993.1619 10.1016/0014-2999(93)90520-R 10.1016/0014-2999(87)90196-8 10.1016/0091-3057(94)00414-E 10.1016/0028-3908(92)90183-P 10.1016/0013-4694(69)90193-X 10.1002/cne.21073 10.1016/j.ejphar.2006.09.027 10.1093/sleep/31.1.21 10.1016/S0006-8993(01)02272-7 10.1053/smrv.2000.0136 10.1016/j.pnpbp.2007.12.024 10.1016/j.bbr.2009.08.037 10.2741/1074 10.1111/j.1460-9568.2009.06718.x 10.1016/0361-9230(78)90064-3 10.1177/026988119601001s01 10.1016/0006-8993(69)90175-9 10.1016/0006-8993(89)90573-8 10.1016/0304-3940(86)90619-1 10.1093/sleep/31.12.1663 10.1196/annals.1296.005 10.1016/0028-3908(94)90067-1 10.1111/j.1365-2869.1994.tb00112.x 10.1016/S0891-0618(98)00036-2 |
| ContentType | Journal Article |
| Copyright | 2011 Elsevier Ltd Elsevier Ltd Copyright © 2010 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2011 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2010 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.smrv.2010.11.003 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1532-2955 |
| EndPage | 281 |
| ExternalDocumentID | 21459634 10_1016_j_smrv_2010_11_003 S1087079210001334 1_s2_0_S1087079210001334 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 123 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5VS 6PF 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFRF ABIVO ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 MOBAO N9A O-L O9- OAUVE OJ- OV. OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSN SSZ T5K UNMZH WOW Z5R ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AADPK AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c461t-edae2c22bbf9e52ce7ed23d008b3c2f8b688298b5c9fe153e00196faee569f6e3 |
| IEDL.DBID | .~1 |
| ISSN | 1087-0792 1532-2955 |
| IngestDate | Fri Jul 11 08:03:28 EDT 2025 Thu Apr 03 07:10:36 EDT 2025 Tue Jul 01 05:27:52 EDT 2025 Thu Apr 24 23:03:03 EDT 2025 Fri Feb 23 02:29:52 EST 2024 Sun Feb 23 10:19:30 EST 2025 Tue Aug 26 16:32:29 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Sleep Serotonin Brain stem Wakefulness Dorsal raphe nucleus Basal forebrain Rapid eye movement sleep Slow wave sleep 5-HT receptors Laterodorsal and pedunculopontine tegmental nuclei |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2010 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c461t-edae2c22bbf9e52ce7ed23d008b3c2f8b688298b5c9fe153e00196faee569f6e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 21459634 |
| PQID | 872524962 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | proquest_miscellaneous_872524962 pubmed_primary_21459634 crossref_citationtrail_10_1016_j_smrv_2010_11_003 crossref_primary_10_1016_j_smrv_2010_11_003 elsevier_sciencedirect_doi_10_1016_j_smrv_2010_11_003 elsevier_clinicalkeyesjournals_1_s2_0_S1087079210001334 elsevier_clinicalkey_doi_10_1016_j_smrv_2010_11_003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-08-01 |
| PublicationDateYYYYMMDD | 2011-08-01 |
| PublicationDate_xml | – month: 08 year: 2011 text: 2011-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Sleep medicine reviews |
| PublicationTitleAlternate | Sleep Med Rev |
| PublicationYear | 2011 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Abrams, Johnson, Hollis, Lowry (bib43) 2004; 1018 Fink, Göthert (bib94) 2007; 59 Morairty, Hedley, Flores, Martin, Kilduff (bib105) 2008; 31 Ponzoni, Monti, Jantos, Altier, Monti (bib127) 1995; 278 Bandelow, Zohar, Hollander, Kasper, Moller (bib1) 2008; 9 Monti, Jantos (bib95) 2006; 30 Jouvet (bib2) 1972; 64 Hobson, Stickgold, Pace-Schott (bib32) 1998; 9 Monti, Orellana, Boussard, Jantos, Labraga, Olivera (bib76) 1990; 7 Monti, Jantos, Monti (bib71) 2002; 12 Oberndorfer, Saletu-Zyhlarz, Saletu (bib85) 2000; 42 Seidel, Cohen, Bliwise, Dement (bib80) 1985; 87 Tortella, Echevarria, Pastel, Cox, Blackburn (bib101) 1989; 485 Martin, Böss, Jenck, Moreau, Mutel, Sleight (bib108) 1998; 286 Roberts, Reavill, East, Harrison, Patel, Routledge (bib61) 2002; 934 Monti, Alterwain, Estévez, Alvariño, Giusti, Olivera (bib136) 1993; 16 Day, Greenwood, Hammack, Watkins, Fleshner, Maier (bib46) 2004; 474 Yamamoto, Mamelak, Quattrochi, Hobson (bib30) 1990; 39 Woolley, Marsden, Fone (bib62) 2004; 3 Adrien (bib150) 2008 Monti, Jantos, Silveira, Reyes-Parada, Scorza, Prunell (bib77) 1994; 115 Torterolo, Morales, Chase (bib144) 2002; 944 Mouret, Bobillier, Jouvet (bib8) 1968; 5 Van Bockstaele, Biswas, Pickel (bib35) 1993; 624 Stanford (bib38) 2001 Monti, Jantos, Lagos (bib88) 2010; 206 Funahashi, Mitoh, Matsuo (bib124) 2004; 26 Ruat, Traiffort, Arrang, Tardivel-Lacombe, Diaz, Leurs (bib60) 1993; 193 Popa, Léna, Fabre, Prenat, Ginrich, Escourrou (bib93) 2005; 25 Imeri, Mancia, Bianchi, Opp (bib17) 2000; 95 Pehec, McFarlane, Maguschak, Price, Pluto (bib113) 2001; 888 Ruiz-Primo, Haro, Valencia (bib135) 1989; 19 Landolt, Wehrle (bib141) 2009; 29 Monti, Jantos (bib86) 2005; 8 Martin-Ruiz, Puig, Celada, Shapiro, Roth, Mengod (bib97) 2001; 21 Dugovic, Wauquier (bib100) 1987; 137 Armitage (bib83) 1996; 10 Hedlund, Huitron-Resendiz, Henriksen, Sutcliffe (bib132) 2005; 58 Adrien, Tissier, Lanfumey, Haj-Dahmane, Jolas, Franc (bib126) 1992; 31 Detari, Rasmusson, Semba (bib148) 1999; 58 Trulson, Jacobs (bib3) 1979; 163 Sørensen, Grønli, Bjorvatn, Ursin (bib72) 2001; 897 Abbas, Roth (bib120) 2008; 9 Bjorvatn, Ursin (bib90) 1994; 3 Adrien, Alexandre, Boutrel, Popa (bib149) 2004; 142 Hammack, Guo, Hazra, Dabrowska, Myers, Rainnie (bib64) 2009; 33 Rechtschaffen, Lovell, Freedman, Whitehead, Aldrich (bib5) 1973 Steinbusch (bib142) 1984; vol. 3 Coenen, Ates, Skarsfeldt, Luijtelaar (bib102) 1995; 51 Imeri, Bianchi, Opp (bib18) 2005; 289 McGinty, Harper (bib67) 1976; 101 Smith, Piper, Duxon, Upton (bib109) 2002; 33 Sheard (bib12) 1969; 15 Reinoso-Suárez, de Andrés, Rodrigo-Angulo, Garzón (bib31) 2001; 5 Jacobs, Azmitia (bib40) 1992; 72 Lerman, Kaitin, Dement, Peroutka (bib78) 1986; 72 Seiden, Hull, Erman, Schwartz, Anderson, Prosser (bib140) 2008; 31 Guo, Hammack, Hazra, Levita, Rainnie (bib56) 2009; 164 Monti, Jantos (bib121) 2008; 32 Parnavelas (bib146) 1990; vol 85 Nair, Gudelsky (bib114) 2004; 53 Cornea-Hébert, Riad, Wu (bib53) 1999; 409 Araneda, Andrade (bib147) 1991; 40 Laporte, Koscielniak, Ponchant, Vergé, Hamon, Gozlan (bib59) 1992; 10 Monti, Jantos (bib74) 2003; 478 Baghdoyan, Lydic (bib24) 2002 Kantor, Jakus, Balogh, Benko, Gagdy (bib111) 2004; 142 Idzikowski, Mills, Glennard (bib116) 1986; 378 Garratt, Kidd, Wright, Marsden (bib96) 1991; 199 Tenen (bib10) 1967; 10 Gillin, Jermajczyk, Valladares-Neto, Golshan, Lardon, Stahl (bib82) 1994; 116 Manfredi, Kales, Vgontzas, Bixler, Isaac, Falcone (bib81) 1991; 148 Morrow, Vikraman, Imeri, Opp (bib19) 2008; 31 Li, Li, Kaneko, Mizuno (bib42) 2001; 900 Wyatt, Engelman, Kupfer, Scott, Sjoerdsma, Snyder (bib4) 1969; 27 Morales, Battenberg, Bloom (bib58) 1998; 402 Kantor, Jakus, Molnar, Gyongyosi, Toth, Detari (bib110) 2005; 315 Clemett, Punhani, Duxon (bib54) 2000; 39 Monti, Jantos (bib104) 2006; 553 Allers, Sharp (bib66) 2003; 122 Amici, Sanford, Kearney, McInemey, Ross, Horner (bib98) 2004; 996 Adam, Oswald (bib134) 1989; 99 Semba (bib34) 1993; 330 Bonhaus, Bach, Desouza (bib55) 1995; 115 Ross, Kenakin (bib151) 2001 Sharpley, Elliott, Attenburrow, Cowen (bib118) 1994; 33 Janowski, Sessack (bib36) 2004; 468 Staner, Luthringer, Macher (bib84) 1999; 11 Boutrel, Franc, Hen, Hamon, Adrien (bib87) 1999; 19 Bagdy, Solyom, Harsing (bib122) 1998; 45 Vertes, Linley (bib39) 2008 Tagliamonte, Tagliamonte, Gessa, Brodie (bib11) 1969; 166 Pace-Schott, Hobson (bib22) 2002 Paiva, Arriaga, Wauquier, Lara, Largo, Leitao (bib138) 1988; 96 Kia, Brisorgueil, Hamon, Calas, Vergé (bib47) 1996; 46 Szymusiak, Gvilia, McGinty (bib25) 2007; 8 Manfridi, Brambilla, Bianchi, Mariotti, Opp, Imeri (bib27) 2003; 18 Sakai, Crochet (bib68) 2001; 104 Portas, Thakkar, Rainnie, McCarley (bib70) 1996; 16 Lacroix, Dawson, Hagan, Heidbreder (bib131) 2003; 51 Dement, Mitler, Henriksen (bib14) 1972; 31 Brambilla, Franciosi, Opp, Imeri (bib28) 2007; 26 Lee, Kim, Valentino, Waterhouse (bib123) 2003; 963 Kirov, Moyanova (bib103) 1998; 93 Jouvet (bib16) 1984; 140 Charara, Parent (bib41) 1998; 15 Ponzoni, Monti, Jantos (bib125) 1993; 249 Idzikowski (bib117) 1989 Vanni-Mercier, Sakai, Lin, Jouvet (bib29) 1989; 127 Monti, Monti, Jantos, Ponzoni (bib91) 1995; 34 da Roza Davies, Sharpley, Cowen (bib137) 1992; 108 Al-Shamma, Anderson, Chuang, Luthringer, Grottick, Hauser (bib106) 2010; 332 Pal, Mallick (bib145) 2004; 365 Levita, Hammack, Mania, Li, Davis, Rainnie (bib21) 2004; 128 Monti, Jantos (bib75) 1992; 1 Abramowski, Rigo, Duc, Hoyer, Staufenbiel (bib52) 1995; 34 Bortolozzi, Diaz-Mataix, Scorza, Celada, Artigas (bib115) 2005; 95 Steiniger, Rye, Wainer (bib33) 1997; 382 Clark, McDevitt, Neumaier (bib48) 2006; 498 Chiang, Aston-Jones (bib112) 1993; 54 Lagos, Torterolo, Jantos, Chase, Monti (bib26) 2009; 1265 Laguzzi, Adrien (bib9) 1980; 118 Frank, Stryker, Tecott (bib92) 2002; 27 Monti, Ponzoni, Jantos, Lagos, Silveira, Banchero (bib128) 1999; 364 Borbély, Huston, Waser (bib13) 1973; 31 Sanford, Ross, Seggos, Morrison, Ball, Mann (bib73) 1994; 49 Gustafson, Durkin, Bard, Zgombick, Brancheck (bib63) 1996; 117 Hannon, Hoyer (bib45) 2008 Sari, Miquel, Brisorgueil, Ruiz, Doucet, Hamon (bib51) 1999; 88 Clancy, Caldwell, Oberleas, Sangiah, Villeneuve (bib7) 1978; 3 Cooper, Bloom, Roth (bib37) 1996 Gehlert, Gackenheimer, Wong (bib57) 1991; 553 Monti, Leopoldo, Jantos (bib133) 2008; 191 Fogel, Beninger, Smith (bib143) 2010; 124 Monti, Jantos (bib107) 2011; 216 Lowry, Evans, Gasser, Hale, Staub, Shekhar (bib44) 2008 Guo, Rainnie (bib49) 2010; 165 Boutrel, Monaca, Hen, Hamon, Adrien (bib69) 2002; 22 Vandermaelen, Aghajanian (bib65) 1983; 289 Staner, Kempenaers, Simonnet, Fransolet, Mendlewicz (bib139) 1992; 86 Ross, Trulson, Jacobs (bib6) 1976; 114 Dawson, Nguyen, Li (bib129) 2000; 130 Khateb, Fort, Alonso, Jones, Mühlthaler (bib20) 1993; 5 Jones (bib23) 2003; 8 Tobler, Borbély (bib15) 1982; 5 Dugovic, Wauquier, Leysen, Janssen (bib99) 1989; 97 Monti, Jantos, Silveira, Reyes-Parada, Scorza (bib79) 1995; 52 Sharpley, Solomon, Fernando, da Roza Davis, Cowen (bib119) 1990; 101 Bruivels, Landwehrmeyer, Gustafson, Durkin, Mengod, Branchek (bib50) 1994; 33 Lemos, Pan, Ma, Lamy, Akanwa, Beck (bib89) 2006; 24 Wolley, Marsden, Sleight, Fone (bib130) 2000; 129 Monti (10.1016/j.smrv.2010.11.003_bib77) 1994; 115 Bandelow (10.1016/j.smrv.2010.11.003_bib1) 2008; 9 Janowski (10.1016/j.smrv.2010.11.003_bib36) 2004; 468 Fogel (10.1016/j.smrv.2010.11.003_bib143) 2010; 124 Ruat (10.1016/j.smrv.2010.11.003_bib60) 1993; 193 Lerman (10.1016/j.smrv.2010.11.003_bib78) 1986; 72 Pal (10.1016/j.smrv.2010.11.003_bib145) 2004; 365 Oberndorfer (10.1016/j.smrv.2010.11.003_bib85) 2000; 42 Kirov (10.1016/j.smrv.2010.11.003_bib103) 1998; 93 Jouvet (10.1016/j.smrv.2010.11.003_bib16) 1984; 140 Wolley (10.1016/j.smrv.2010.11.003_bib130) 2000; 129 Frank (10.1016/j.smrv.2010.11.003_bib92) 2002; 27 Adam (10.1016/j.smrv.2010.11.003_bib134) 1989; 99 Ponzoni (10.1016/j.smrv.2010.11.003_bib125) 1993; 249 Allers (10.1016/j.smrv.2010.11.003_bib66) 2003; 122 Tobler (10.1016/j.smrv.2010.11.003_bib15) 1982; 5 Manfridi (10.1016/j.smrv.2010.11.003_bib27) 2003; 18 Sharpley (10.1016/j.smrv.2010.11.003_bib119) 1990; 101 Kia (10.1016/j.smrv.2010.11.003_bib47) 1996; 46 Imeri (10.1016/j.smrv.2010.11.003_bib17) 2000; 95 Seidel (10.1016/j.smrv.2010.11.003_bib80) 1985; 87 Clark (10.1016/j.smrv.2010.11.003_bib48) 2006; 498 Guo (10.1016/j.smrv.2010.11.003_bib49) 2010; 165 Steinbusch (10.1016/j.smrv.2010.11.003_bib142) 1984; vol. 3 Araneda (10.1016/j.smrv.2010.11.003_bib147) 1991; 40 Clemett (10.1016/j.smrv.2010.11.003_bib54) 2000; 39 Smith (10.1016/j.smrv.2010.11.003_bib109) 2002; 33 Hannon (10.1016/j.smrv.2010.11.003_bib45) 2008 Gillin (10.1016/j.smrv.2010.11.003_bib82) 1994; 116 Al-Shamma (10.1016/j.smrv.2010.11.003_bib106) 2010; 332 Clancy (10.1016/j.smrv.2010.11.003_bib7) 1978; 3 Monti (10.1016/j.smrv.2010.11.003_bib121) 2008; 32 Monti (10.1016/j.smrv.2010.11.003_bib71) 2002; 12 Dugovic (10.1016/j.smrv.2010.11.003_bib99) 1989; 97 Day (10.1016/j.smrv.2010.11.003_bib46) 2004; 474 Hammack (10.1016/j.smrv.2010.11.003_bib64) 2009; 33 Staner (10.1016/j.smrv.2010.11.003_bib139) 1992; 86 Garratt (10.1016/j.smrv.2010.11.003_bib96) 1991; 199 Bonhaus (10.1016/j.smrv.2010.11.003_bib55) 1995; 115 Seiden (10.1016/j.smrv.2010.11.003_bib140) 2008; 31 Cooper (10.1016/j.smrv.2010.11.003_bib37) 1996 Tagliamonte (10.1016/j.smrv.2010.11.003_bib11) 1969; 166 Kantor (10.1016/j.smrv.2010.11.003_bib110) 2005; 315 Monti (10.1016/j.smrv.2010.11.003_bib86) 2005; 8 Nair (10.1016/j.smrv.2010.11.003_bib114) 2004; 53 Bruivels (10.1016/j.smrv.2010.11.003_bib50) 1994; 33 Guo (10.1016/j.smrv.2010.11.003_bib56) 2009; 164 Torterolo (10.1016/j.smrv.2010.11.003_bib144) 2002; 944 Gustafson (10.1016/j.smrv.2010.11.003_bib63) 1996; 117 Sakai (10.1016/j.smrv.2010.11.003_bib68) 2001; 104 Monti (10.1016/j.smrv.2010.11.003_bib79) 1995; 52 Adrien (10.1016/j.smrv.2010.11.003_bib126) 1992; 31 Monti (10.1016/j.smrv.2010.11.003_bib136) 1993; 16 Sanford (10.1016/j.smrv.2010.11.003_bib73) 1994; 49 Landolt (10.1016/j.smrv.2010.11.003_bib141) 2009; 29 Detari (10.1016/j.smrv.2010.11.003_bib148) 1999; 58 Abrams (10.1016/j.smrv.2010.11.003_bib43) 2004; 1018 Jouvet (10.1016/j.smrv.2010.11.003_bib2) 1972; 64 Abramowski (10.1016/j.smrv.2010.11.003_bib52) 1995; 34 Boutrel (10.1016/j.smrv.2010.11.003_bib69) 2002; 22 Jacobs (10.1016/j.smrv.2010.11.003_bib40) 1992; 72 Martin (10.1016/j.smrv.2010.11.003_bib108) 1998; 286 Pehec (10.1016/j.smrv.2010.11.003_bib113) 2001; 888 Jones (10.1016/j.smrv.2010.11.003_bib23) 2003; 8 Lacroix (10.1016/j.smrv.2010.11.003_bib131) 2003; 51 Brambilla (10.1016/j.smrv.2010.11.003_bib28) 2007; 26 Ross (10.1016/j.smrv.2010.11.003_bib151) 2001 da Roza Davies (10.1016/j.smrv.2010.11.003_bib137) 1992; 108 Imeri (10.1016/j.smrv.2010.11.003_bib18) 2005; 289 Sharpley (10.1016/j.smrv.2010.11.003_bib118) 1994; 33 Stanford (10.1016/j.smrv.2010.11.003_bib38) 2001 Laguzzi (10.1016/j.smrv.2010.11.003_bib9) 1980; 118 Ponzoni (10.1016/j.smrv.2010.11.003_bib127) 1995; 278 Woolley (10.1016/j.smrv.2010.11.003_bib62) 2004; 3 Fink (10.1016/j.smrv.2010.11.003_bib94) 2007; 59 Adrien (10.1016/j.smrv.2010.11.003_bib150) 2008 Lemos (10.1016/j.smrv.2010.11.003_bib89) 2006; 24 Li (10.1016/j.smrv.2010.11.003_bib42) 2001; 900 Steiniger (10.1016/j.smrv.2010.11.003_bib33) 1997; 382 Paiva (10.1016/j.smrv.2010.11.003_bib138) 1988; 96 Ross (10.1016/j.smrv.2010.11.003_bib6) 1976; 114 Tenen (10.1016/j.smrv.2010.11.003_bib10) 1967; 10 Bjorvatn (10.1016/j.smrv.2010.11.003_bib90) 1994; 3 Armitage (10.1016/j.smrv.2010.11.003_bib83) 1996; 10 Morairty (10.1016/j.smrv.2010.11.003_bib105) 2008; 31 Monti (10.1016/j.smrv.2010.11.003_bib91) 1995; 34 Vandermaelen (10.1016/j.smrv.2010.11.003_bib65) 1983; 289 Monti (10.1016/j.smrv.2010.11.003_bib133) 2008; 191 Idzikowski (10.1016/j.smrv.2010.11.003_bib117) 1989 Manfredi (10.1016/j.smrv.2010.11.003_bib81) 1991; 148 Bortolozzi (10.1016/j.smrv.2010.11.003_bib115) 2005; 95 Laporte (10.1016/j.smrv.2010.11.003_bib59) 1992; 10 Pace-Schott (10.1016/j.smrv.2010.11.003_bib22) 2002 Monti (10.1016/j.smrv.2010.11.003_bib88) 2010; 206 Van Bockstaele (10.1016/j.smrv.2010.11.003_bib35) 1993; 624 Cornea-Hébert (10.1016/j.smrv.2010.11.003_bib53) 1999; 409 Monti (10.1016/j.smrv.2010.11.003_bib74) 2003; 478 Dugovic (10.1016/j.smrv.2010.11.003_bib100) 1987; 137 Yamamoto (10.1016/j.smrv.2010.11.003_bib30) 1990; 39 Morales (10.1016/j.smrv.2010.11.003_bib58) 1998; 402 Dement (10.1016/j.smrv.2010.11.003_bib14) 1972; 31 Mouret (10.1016/j.smrv.2010.11.003_bib8) 1968; 5 Trulson (10.1016/j.smrv.2010.11.003_bib3) 1979; 163 Sheard (10.1016/j.smrv.2010.11.003_bib12) 1969; 15 Hobson (10.1016/j.smrv.2010.11.003_bib32) 1998; 9 Monti (10.1016/j.smrv.2010.11.003_bib76) 1990; 7 Borbély (10.1016/j.smrv.2010.11.003_bib13) 1973; 31 Idzikowski (10.1016/j.smrv.2010.11.003_bib116) 1986; 378 Coenen (10.1016/j.smrv.2010.11.003_bib102) 1995; 51 Amici (10.1016/j.smrv.2010.11.003_bib98) 2004; 996 Monti (10.1016/j.smrv.2010.11.003_bib128) 1999; 364 Baghdoyan (10.1016/j.smrv.2010.11.003_bib24) 2002 Lee (10.1016/j.smrv.2010.11.003_bib123) 2003; 963 Monti (10.1016/j.smrv.2010.11.003_bib75) 1992; 1 Boutrel (10.1016/j.smrv.2010.11.003_bib87) 1999; 19 Lowry (10.1016/j.smrv.2010.11.003_bib44) 2008 Morrow (10.1016/j.smrv.2010.11.003_bib19) 2008; 31 Parnavelas (10.1016/j.smrv.2010.11.003_bib146) 1990; vol 85 Roberts (10.1016/j.smrv.2010.11.003_bib61) 2002; 934 Dawson (10.1016/j.smrv.2010.11.003_bib129) 2000; 130 McGinty (10.1016/j.smrv.2010.11.003_bib67) 1976; 101 Sørensen (10.1016/j.smrv.2010.11.003_bib72) 2001; 897 Gehlert (10.1016/j.smrv.2010.11.003_bib57) 1991; 553 Vanni-Mercier (10.1016/j.smrv.2010.11.003_bib29) 1989; 127 Szymusiak (10.1016/j.smrv.2010.11.003_bib25) 2007; 8 Levita (10.1016/j.smrv.2010.11.003_bib21) 2004; 128 Bagdy (10.1016/j.smrv.2010.11.003_bib122) 1998; 45 Lagos (10.1016/j.smrv.2010.11.003_bib26) 2009; 1265 Rechtschaffen (10.1016/j.smrv.2010.11.003_bib5) 1973 Semba (10.1016/j.smrv.2010.11.003_bib34) 1993; 330 Martin-Ruiz (10.1016/j.smrv.2010.11.003_bib97) 2001; 21 Abbas (10.1016/j.smrv.2010.11.003_bib120) 2008; 9 Popa (10.1016/j.smrv.2010.11.003_bib93) 2005; 25 Khateb (10.1016/j.smrv.2010.11.003_bib20) 1993; 5 Hedlund (10.1016/j.smrv.2010.11.003_bib132) 2005; 58 Adrien (10.1016/j.smrv.2010.11.003_bib149) 2004; 142 Portas (10.1016/j.smrv.2010.11.003_bib70) 1996; 16 Monti (10.1016/j.smrv.2010.11.003_bib95) 2006; 30 Charara (10.1016/j.smrv.2010.11.003_bib41) 1998; 15 Sari (10.1016/j.smrv.2010.11.003_bib51) 1999; 88 Kantor (10.1016/j.smrv.2010.11.003_bib111) 2004; 142 Vertes (10.1016/j.smrv.2010.11.003_bib39) 2008 Monti (10.1016/j.smrv.2010.11.003_bib104) 2006; 553 Chiang (10.1016/j.smrv.2010.11.003_bib112) 1993; 54 Funahashi (10.1016/j.smrv.2010.11.003_bib124) 2004; 26 Wyatt (10.1016/j.smrv.2010.11.003_bib4) 1969; 27 Reinoso-Suárez (10.1016/j.smrv.2010.11.003_bib31) 2001; 5 Staner (10.1016/j.smrv.2010.11.003_bib84) 1999; 11 Tortella (10.1016/j.smrv.2010.11.003_bib101) 1989; 485 Monti (10.1016/j.smrv.2010.11.003_bib107) 2011; 216 Ruiz-Primo (10.1016/j.smrv.2010.11.003_bib135) 1989; 19 |
| References_xml | – volume: 934 start-page: 49 year: 2002 end-page: 57 ident: bib61 article-title: The distribution of 5-HT publication-title: Brain Res – volume: 963 start-page: 57 year: 2003 end-page: 71 ident: bib123 article-title: Glutamatergic afferent projections to the dorsal raphe nucleus of the rat publication-title: Brain Res – volume: 624 start-page: 188 year: 1993 end-page: 198 ident: bib35 article-title: Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens publication-title: Brain Res – volume: 86 start-page: 133 year: 1992 end-page: 137 ident: bib139 article-title: 5-HT2 receptor antagonism and slow wave sleep in major depression publication-title: Acta Psychiatr Scand – volume: 46 start-page: 697 year: 1996 end-page: 708 ident: bib47 article-title: Ultrastructural localization of 5 -hydroxytryptamine publication-title: J Neurosci Res – volume: 8 start-page: 291 year: 2007 end-page: 301 ident: bib25 article-title: Hypothalamic control of sleep publication-title: Sleep Med – volume: 42 start-page: 69 year: 2000 end-page: 81 ident: bib85 article-title: Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality publication-title: Neuropsychobiology – volume: 382 start-page: 302 year: 1997 end-page: 322 ident: bib33 article-title: Serotonergic dorsal raphe nucleus projections to the cholinergic and noncholinergic neurons of the pedunculopontine tegmental region: a light and electron microscopic anterograde tracing and immunohistochemical study publication-title: J Comp Neurol – volume: 216 start-page: 381 year: 2011 end-page: 388 ident: bib107 article-title: Effects of the 5-HT publication-title: Behav Brain Res – start-page: 69 year: 2008 end-page: 102 ident: bib39 article-title: Efferent and afferent connections of the dorsal and median raphe nuclei in the rat publication-title: Serotonin and sleep: molecular, functional and clinical aspects – volume: 478 start-page: 121 year: 2003 end-page: 130 ident: bib74 article-title: Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat publication-title: Eur J Pharmacol – volume: 59 start-page: 360 year: 2007 end-page: 417 ident: bib94 article-title: 5-HT receptor regulation of neurotransmitter release publication-title: Pharmacol Rev – volume: 39 start-page: 279 year: 1990 end-page: 293 ident: bib30 article-title: A cholinoceptive desynchronized sleep induction zone in the anterodorsal pontine tegmentum: locus of the sensitive region publication-title: Neuroscience – volume: 5 start-page: 145 year: 1982 end-page: 153 ident: bib15 article-title: Sleep regulation after reduction of brain serotonin: effect of p-chlorophenylalanine combined with sleep deprivation in the rat publication-title: Sleep – volume: 3 start-page: 59 year: 2004 end-page: 79 ident: bib62 article-title: 5-HT publication-title: Curr Drug Targets CNS Neurol Disord – volume: 19 start-page: 72 year: 1989 ident: bib135 article-title: Polysomnographic effects of ritanserin in insomniacs. A crossed double-blind controlled study publication-title: Sleep Res – volume: 553 start-page: 163 year: 2006 end-page: 170 ident: bib104 article-title: Effects of the serotonin 5-HT publication-title: Eur J Pharmacol – volume: 286 start-page: 913 year: 1998 end-page: 924 ident: bib108 article-title: 5-HT publication-title: J Pharmacol Exp Ther – volume: 3 start-page: 83 year: 1978 end-page: 87 ident: bib7 article-title: Effects of chronic tryptophan dietary deficiency on the rat’s sleep-wake cycle publication-title: Brain Res Bull – volume: 32 start-page: 9407 year: 2008 ident: bib121 article-title: Activation of the serotonin 5-HT publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry – volume: 52 start-page: 305 year: 1995 end-page: 312 ident: bib79 article-title: Sleep and waking in 5,7-DHT-lesioned or (−)pindolol-pretreated rats after administration of buspirone, ipsapirone or gepirone publication-title: Pharmacol Biochem Behav – volume: 24 start-page: 3415 year: 2006 end-page: 3430 ident: bib89 article-title: Selective 5-HT publication-title: Eur J Neurosci – volume: 498 start-page: 611 year: 2006 end-page: 623 ident: bib48 article-title: Quantitative mapping of tryptophan hydroxylase-2, 5-HT publication-title: J Comp Neurol – volume: 29 start-page: 1795 year: 2009 end-page: 1809 ident: bib141 article-title: Antagonist of serotonergic 5-HT publication-title: Eur J Neurosci – volume: 10 start-page: 22 year: 1996 end-page: 25 ident: bib83 article-title: Effects of antidepressant treatment on sleep EEG in depression publication-title: J Psychopharmacol – volume: 87 start-page: 371 year: 1985 end-page: 373 ident: bib80 article-title: Buspirone: and anxiolytic without sedative effect publication-title: Psychopharmacology – volume: 1 start-page: 169 year: 1992 end-page: 175 ident: bib75 article-title: Dose-dependent effects of the 5-HT publication-title: J Sleep Res – volume: 15 start-page: 111 year: 1998 end-page: 127 ident: bib41 article-title: Chemoarchitecture of the primate dorsal raphe nucleus publication-title: J Chem Neuroanat – volume: 3 start-page: 97 year: 1994 end-page: 105 ident: bib90 article-title: Effects of the selective 5-HT publication-title: J Sleep Res – volume: 193 start-page: 268 year: 1993 end-page: 276 ident: bib60 article-title: A novel rat serotonin (5-HT publication-title: Biochem Biophys Res Comm – volume: 40 start-page: 399 year: 1991 end-page: 412 ident: bib147 article-title: 5-Hydroxytryptamine publication-title: Neuroscience – volume: 163 start-page: 135 year: 1979 end-page: 150 ident: bib3 article-title: Raphe unit activity in freely moving cats: correlation with level of behavioral arousal publication-title: Brain Res – volume: 58 start-page: 831 year: 2005 end-page: 837 ident: bib132 article-title: 5-HT publication-title: Biol Psychiatry – start-page: 25 year: 2008 end-page: 62 ident: bib44 article-title: Topographic organization and chemoarchitecture of the dorsal raphe nucleus and the median raphe nucleus publication-title: Serotonin and sleep: molecular, functional and clinical aspects – volume: 191 start-page: 184 year: 2008 end-page: 189 ident: bib133 article-title: The serotonin 5-HT publication-title: Behav Brain Res – volume: 128 start-page: 583 year: 2004 end-page: 596 ident: bib21 article-title: 5-hydroxytryptamine publication-title: Neuroscience – volume: 130 start-page: 23 year: 2000 end-page: 26 ident: bib129 article-title: In vivo effects of the 5-HT publication-title: Br J Pharmacol – volume: 31 start-page: 21 year: 2008 end-page: 33 ident: bib19 article-title: Effects of serotonergic activation by5-hydroxytryptophan on sleep and body temperature of C57BL/6J and interleukin-6-deficient mice are dose and time related publication-title: Sleep – volume: 468 start-page: 518 year: 2004 end-page: 529 ident: bib36 article-title: Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and association with serotonin and gamma-aminobutyric acid neurons publication-title: J Comp Neurol – volume: 409 start-page: 187 year: 1999 end-page: 209 ident: bib53 article-title: Cellular and subcellular distribution of the serotonin 5-HT publication-title: J Comp Neurol – volume: 72 start-page: 64 year: 1986 end-page: 68 ident: bib78 article-title: The effect of buspirone on sleep in the rat publication-title: Neurosci Lett – volume: vol 85 start-page: 13 year: 1990 end-page: 29 ident: bib146 article-title: Neurotransmitters in the cerebral cortex publication-title: Progress brain research – start-page: 187 year: 2001 end-page: 209 ident: bib38 article-title: 5-Hydroxytryptamine publication-title: Neurotransmitters, drugs and brain function – volume: 8 start-page: 438 year: 2003 end-page: 451 ident: bib23 article-title: Arousal systems publication-title: Front Biosci – volume: 34 start-page: 1647 year: 1995 end-page: 1651 ident: bib91 article-title: Effects of selective activation of the 5-HT publication-title: Neuropharmacology – volume: 97 start-page: 436 year: 1989 end-page: 442 ident: bib99 article-title: Functional role of 5-HT publication-title: Psychopharmacology – volume: 166 start-page: 1433 year: 1969 end-page: 1435 ident: bib11 article-title: Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized male rats publication-title: Science – volume: 101 start-page: 569 year: 1976 end-page: 575 ident: bib67 article-title: Dorsal raphe neurons: depression of firing during sleep publication-title: Brain Res – volume: 95 start-page: 1597 year: 2005 end-page: 1607 ident: bib115 article-title: The activation of 5-HT publication-title: J Neurochem – volume: 26 start-page: 615 year: 2004 end-page: 622 ident: bib124 article-title: Activation of presynaptic 5-HT publication-title: Methods Find Exp Clin Pharmacol – volume: 10 start-page: 204 year: 1967 end-page: 219 ident: bib10 article-title: The effects of p-chlorophenylalanine, a serotonin depletor on avoidance adquisition, pain sensitivity and related behavior in the rat publication-title: Psychopharmacology – volume: 33 start-page: 367 year: 1994 end-page: 386 ident: bib50 article-title: Localization of 5-HT publication-title: Neuropharmacology – volume: 18 start-page: 1041 year: 2003 end-page: 1049 ident: bib27 article-title: Interleukin1β enhances non-rapid eye movement sleep when microinjected into the dorsal raphe nucleus and inhibits serotonergic neurons in vitro publication-title: Eur J Neurosci – volume: 330 start-page: 543 year: 1993 end-page: 556 ident: bib34 article-title: Aminergic and cholinergic afferents to REM sleep induction regions of the pontine reticular formation in the rat publication-title: J Comp Neurol – volume: 5 start-page: 63 year: 2001 end-page: 77 ident: bib31 article-title: Brain structures and mechanisms involved in the generation of REM sleep publication-title: Sleep Med Rev – volume: 88 start-page: 899 year: 1999 end-page: 915 ident: bib51 article-title: Cellular and subcellullar localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies publication-title: Neuroscience – volume: 116 start-page: 433 year: 1994 end-page: 436 ident: bib82 article-title: Inhibition of REM sleep by ipsapirone, a 5-HT publication-title: Psychopharmacology – volume: 21 start-page: 9856 year: 2001 end-page: 9866 ident: bib97 article-title: Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism publication-title: J Neurosci – volume: 118 start-page: 109 year: 1980 end-page: 123 ident: bib9 article-title: Inversion de l'insomnie produit par la chlorophenylalanine chez le chat publication-title: Arch Ital Biol – volume: 122 start-page: 193 year: 2003 end-page: 204 ident: bib66 article-title: Neurochemical and anatomical identification of fast- and slow-firing neurons in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo publication-title: Neuroscience – volume: vol. 3 start-page: 68 year: 1984 end-page: 125 ident: bib142 article-title: Serotonin-immunoreactive neurons and their projections in the CNS publication-title: Handbook of chemical neuroanatomy – volume: 888 start-page: 51 year: 2001 end-page: 59 ident: bib113 article-title: M100,907, a selective 5-HT(2A) antagonist attenuates dopamine release in the rat medial prefrontal cortex publication-title: Brain Res – volume: 45 start-page: 203 year: 1998 end-page: 208 ident: bib122 article-title: Feedback stimulation of somatodendritic serotonin release: a 5-HT publication-title: Brain Res Bull – volume: 148 start-page: 1213 year: 1991 end-page: 1217 ident: bib81 article-title: Buspirone: sedative or stimulant effect? publication-title: Am J Psychiatry – volume: 31 start-page: 34 year: 2008 end-page: 44 ident: bib105 article-title: Selective 5-HT publication-title: Sleep – volume: 365 start-page: 200 year: 2004 end-page: 204 ident: bib145 article-title: GABA en pedunculopontine tegmentum regulates spontaneous rapid eye movement sleep by acting on GABA publication-title: Neurosci Lett – volume: 9 start-page: 3251 year: 2008 end-page: 3259 ident: bib120 article-title: Pimavanserin tartrate: a 5-HT publication-title: Expert Opin Pharmacother – volume: 1018 start-page: 46 year: 2004 end-page: 57 ident: bib43 article-title: Anatomic and functional topography of the dorsal raphe nucleus publication-title: Ann N Y Acad Sci – volume: 199 start-page: 349 year: 1991 end-page: 355 ident: bib96 article-title: Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI publication-title: Eur J Pharmacol – volume: 289 start-page: 1009 year: 1983 end-page: 1019 ident: bib65 article-title: Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices publication-title: Brain Res – volume: 1265 start-page: 103 year: 2009 end-page: 110 ident: bib26 article-title: Effects on sleep of melanin-concentrating hormone (MCH) microinjections into the dorsal raphe nucleus publication-title: Brain Res – volume: 16 start-page: 647 year: 1993 end-page: 654 ident: bib136 article-title: The effects of ritanserin on mood and sleep in abstinent alcoholic patients publication-title: Sleep – volume: 996 start-page: 9 year: 2004 end-page: 18 ident: bib98 article-title: A serotonergic (5-HT publication-title: Brain Res – volume: 5 start-page: 541 year: 1993 end-page: 547 ident: bib20 article-title: Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons publication-title: Eur J Neurosci – volume: 22 start-page: 4686 year: 2002 end-page: 4692 ident: bib69 article-title: Involvement of 5-HT publication-title: J Neurosci – volume: 96 start-page: 395 year: 1988 end-page: 399 ident: bib138 article-title: Effect of ritanserin on sleep disturbances in dysthymic patients publication-title: Psychopharmacology – volume: 114 start-page: 517 year: 1976 end-page: 523 ident: bib6 article-title: Depletion of brain 5-HT following intraventricular 5,7-dihydroxytryptamine fails to disrupt sleep in the rat publication-title: Brain Res – year: 1996 ident: bib37 article-title: The biochemical basis of neuropharmacology – volume: 278 start-page: 111 year: 1995 end-page: 115 ident: bib127 article-title: Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists publication-title: Eur J Pharmacol – volume: 95 start-page: 445 year: 2000 end-page: 452 ident: bib17 article-title: 5-Hydroxytryptophan, but not l-tryptophan, alters sleep and brain temperature in rats publication-title: Neuroscience – volume: 33 start-page: 467 year: 1994 end-page: 471 ident: bib118 article-title: Slow wave sleep in humans: role of 5-HT publication-title: Neuropharmacology – volume: 165 start-page: 1390 year: 2010 end-page: 1401 ident: bib49 article-title: Presynaptic 5-HT publication-title: Neuroscience – volume: 101 start-page: 568 year: 1990 end-page: 569 ident: bib119 article-title: Dose-related effects of selective 5-HT publication-title: Psychopharmacology – volume: 31 start-page: 1663 year: 2008 end-page: 1671 ident: bib140 article-title: APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia publication-title: Sleep – volume: 51 start-page: 158 year: 2003 end-page: 164 ident: bib131 article-title: 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex publication-title: Synapse – volume: 54 start-page: 409 year: 1993 end-page: 420 ident: bib112 article-title: 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons publication-title: Neuroscience – volume: 30 start-page: 1189 year: 2006 end-page: 1195 ident: bib95 article-title: Effects of activation and blockade of 5-HT publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry – volume: 124 start-page: 79 year: 2010 end-page: 86 ident: bib143 article-title: Increased GABAergic activity in the region of the pedunculopontine and deep mesencephalic reticular nuclei reduces REM sleep and impairs learning in rats publication-title: Behav Neurosci – volume: 117 start-page: 657 year: 1996 end-page: 666 ident: bib63 article-title: A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-HT publication-title: Br J Pharmacol – volume: 142 start-page: 369 year: 2004 end-page: 377 ident: bib149 article-title: Contribution of the “knock-out” technology to understanding the role of serotonin in sleep regulations publication-title: Ach Ital Biol – volume: 49 start-page: 93 year: 1994 end-page: 100 ident: bib73 article-title: Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves publication-title: Pharmacol Biochem Behav – volume: 31 start-page: 519 year: 1992 end-page: 529 ident: bib126 article-title: Central action of 5-HT publication-title: Neuropharmacology – volume: 72 start-page: 165 year: 1992 end-page: 229 ident: bib40 article-title: Structure and function of the brain serotonin system publication-title: Physiol Rev – volume: 206 start-page: 8 year: 2010 end-page: 16 ident: bib88 article-title: Activation of serotonin 5-HT publication-title: Behav Brain Res – volume: 25 start-page: 11231 year: 2005 end-page: 11238 ident: bib93 article-title: Contribution of 5-HT publication-title: J Neurosci – volume: 58 start-page: 249 year: 1999 end-page: 277 ident: bib148 article-title: The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex publication-title: Prog Neurobiol – volume: 249 start-page: 259 year: 1993 end-page: 264 ident: bib125 article-title: The effects of selective activation of the 5-HT publication-title: Eur J Pharmacol – volume: 104 start-page: 1141 year: 2001 end-page: 1155 ident: bib68 article-title: Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake–sleep states publication-title: Neuroscience – volume: 64 start-page: 166 year: 1972 end-page: 307 ident: bib2 article-title: The role of monoamines and acetylcholine containing neurons in the regulation of the sleep–waking cycle publication-title: Ergeb Physiol – volume: 289 start-page: R1116 year: 2005 end-page: 1123 ident: bib18 article-title: Antagonism of corticotropin-releasing hormone alters serotonergic-induced changes in brain temperature, but not sleep, of rats publication-title: Am J Physiol Regul Integr Comp Physiol – volume: 485 start-page: 294 year: 1989 end-page: 300 ident: bib101 article-title: Suppressant effects of selective 5-HT publication-title: Brain Res – volume: 7 start-page: 145 year: 1990 end-page: 151 ident: bib76 article-title: 5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 8-OH-DPAT increase wakefulness in the rat publication-title: Biogen Amines – volume: 93 start-page: 257 year: 1998 end-page: 264 ident: bib103 article-title: Age-dependent effect of ketanserin on the sleep–waking phases in rats publication-title: Int J Neurosci – volume: 9 start-page: 248 year: 2008 end-page: 312 ident: bib1 article-title: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision publication-title: World J Biol Psychiatry – volume: 164 start-page: 1776 year: 2009 end-page: 1793 ident: bib56 article-title: Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes publication-title: Neuroscience – volume: 378 start-page: 164 year: 1986 end-page: 168 ident: bib116 article-title: 5-Hydroxytryptamine-2 antagonist ritanserin increases human slow wave sleep publication-title: Brain Res – volume: 315 start-page: 921 year: 2005 end-page: 930 ident: bib110 article-title: Despite similar anxiolytic potential, the 5-hydroxytryptamine2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra publication-title: J Pharmacol Exp Ther – volume: 16 start-page: 2820 year: 1996 end-page: 2828 ident: bib70 article-title: Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) into the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving rat publication-title: J Neurosci – volume: 127 start-page: 133 year: 1989 end-page: 164 ident: bib29 article-title: Mapping of cholinoceptive brainstem structures responsible for the generation of paradoxical sleep in the cat publication-title: Arch Ital Biol – volume: 142 start-page: 1332 year: 2004 end-page: 1342 ident: bib111 article-title: Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT publication-title: Br J Pharmacol – volume: 137 start-page: 145 year: 1987 end-page: 146 ident: bib100 article-title: 5-HT publication-title: Eur J Pharmacol – volume: 129 start-page: 64P year: 2000 ident: bib130 article-title: Reversal of a scopolamine-induced deficit in object discrimination by a selective 5-HT6 receptor antagonist, RO-046790, in rats publication-title: Br J Pharmacol – volume: 99 start-page: 219 year: 1989 end-page: 221 ident: bib134 article-title: Effects of repeated ritanserin on middle-aged poor sleepers publication-title: Psychopharmacology – volume: 15 start-page: 524 year: 1969 end-page: 528 ident: bib12 article-title: The effects of p-chlorophenylalanine on behavior in rats: relation to brain serotonin and 5-hydroxyindolacetic acid publication-title: Brain Res – volume: 53 start-page: 202 year: 2004 end-page: 207 ident: bib114 article-title: Activation of 5-HT publication-title: Synapse – volume: 31 start-page: 239 year: 1972 end-page: 246 ident: bib14 article-title: Sleep changes during chronic administration of parachlorophenylalanine publication-title: Can J Biol – volume: 332 start-page: 281 year: 2010 end-page: 290 ident: bib106 article-title: Nelotanserin, a novel selective human 5-hydroxytryptamine publication-title: J Pharmacol Exp Ther – volume: 115 start-page: 273 year: 1994 end-page: 277 ident: bib77 article-title: Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat publication-title: Psychopharmacology – volume: 31 start-page: 131 year: 1973 end-page: 142 ident: bib13 article-title: Physiological and behavioral effects of parachlorophenylalanine in the rat publication-title: Psychopharmacology – volume: 27 start-page: 529 year: 1969 end-page: 532 ident: bib4 article-title: Effects of para-chlorophenylalanine on sleep in man publication-title: Electroencephalogr Clin Neurophysiol – volume: 10 start-page: 2771 year: 1992 end-page: 2781 ident: bib59 article-title: Quantitative autoradiographic mapping of 5-HT publication-title: Synapse – volume: 33 start-page: 467 year: 2002 end-page: 471 ident: bib109 article-title: Effect of SB-243213, a selective 5-HT publication-title: Pharmacol Biochem Behav – volume: 11 start-page: 49 year: 1999 end-page: 60 ident: bib84 article-title: Effects of antidepressant drugs on sleep EEG in patients with major depression publication-title: Cent Nerv Syst Drugs – start-page: 155 year: 2008 end-page: 182 ident: bib45 article-title: Molecular biology of 5-HT receptors publication-title: Serotonin and sleep: molecular, functional and clinical aspects – volume: 553 start-page: 149 year: 1991 end-page: 154 ident: bib57 article-title: Localization of 5-HT3 receptors in the rat using [ publication-title: Brain Res – start-page: 197 year: 1989 end-page: 215 ident: bib117 article-title: The effects of ritanserin and seganserin on human slow wave sleep publication-title: Slow wave sleep –physiological, pathophysiological and functional aspects – start-page: 1859 year: 2002 end-page: 1877 ident: bib22 article-title: Basic mechanisms of sleep: New evidence on the neuroanatomy and neuromodulation of the NREM–REM cycle publication-title: Neuropsychopharmacology – the fifth generation of progress – volume: 8 start-page: 75 year: 2005 end-page: 86 ident: bib86 article-title: A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat publication-title: Int J Neuropsychopharmacol – volume: 944 start-page: 1 year: 2002 end-page: 9 ident: bib144 article-title: GABAergic mechanisms in the pedunculopontine tegmental nucleus of the cat promote active (REM) sleep publication-title: Brain Res – volume: 402 start-page: 385 year: 1998 end-page: 401 ident: bib58 article-title: Distribution of neurons expressing immunoreactivity for the 5-HT publication-title: J Comp Neurol – volume: 474 start-page: 464 year: 2004 end-page: 478 ident: bib46 article-title: Differential expression of 5-HT1A, alpha(1B) adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus publication-title: J Comp Neurol – volume: 115 start-page: 622 year: 1995 end-page: 628 ident: bib55 article-title: The pharmacology and distribution of human 5-hydroxytryptamine(2B) (5-HT publication-title: Br J Pharmacol – volume: 897 start-page: 122 year: 2001 end-page: 130 ident: bib72 article-title: Sleep and waking following microdialysis perfusion of the selective 5-HT publication-title: Brain Res – volume: 12 start-page: 47 year: 2002 end-page: 77 ident: bib71 article-title: Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OH-DPAT: prevention with WAY 100635 publication-title: Eur Neuropsychopharmacol – volume: 51 start-page: 353 year: 1995 end-page: 357 ident: bib102 article-title: Effects of sertindole on sleep–wake states, electroencephalogram, behavioral patterns, and epileptic activity in rats publication-title: Pharmacol Biochem Behav – start-page: 401 year: 1973 end-page: 418 ident: bib5 article-title: The effect of para-chlorophenylalanine in the rat: some implications for the serotonin-sleep hypothesis publication-title: Serotonin and behavior – start-page: 17 year: 2002 end-page: 44 ident: bib24 article-title: Neurotransmitters and neuromodulators regulating sleep publication-title: Sleep and epilepsy: the clinical spectrum – volume: 26 start-page: 1862 year: 2007 end-page: 1869 ident: bib28 article-title: Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials publication-title: Eur J Neurosci – volume: 27 start-page: 869 year: 2002 end-page: 873 ident: bib92 article-title: Sleep and sleep homeostasis in mice lacking the 5-HT publication-title: Neuropsychopharmacology – volume: 140 start-page: 389 year: 1984 end-page: 400 ident: bib16 article-title: Neuromediateurs et facteurs hypnogènes publication-title: Rev Neurol – volume: 364 start-page: 89 year: 1999 end-page: 98 ident: bib128 article-title: Effects of accumbens m-chlorophenylbiguanide microinjection on sleep and waking in intact and 6-hydroxydopamine-treated rats publication-title: Eur J Pharmacol – volume: 5 start-page: 17 year: 1968 end-page: 22 ident: bib8 article-title: Insomnia following parachlorophenylalanine in the rat publication-title: Eur J Pharmacol – volume: 33 start-page: 1309 year: 2009 end-page: 1320 ident: bib64 article-title: The response of neurons of the bed nucleus of the stria terminalis to serotonin: implications for anxiety publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 9 start-page: R1 year: 1998 end-page: R14 ident: bib32 article-title: The neuropsychology of REM sleep dreaming publication-title: Neuroreport – volume: 900 start-page: 110 year: 2001 end-page: 118 ident: bib42 article-title: Morphological features and electrophysiological properties of serotonergic and non-serotonergic projection neurons in the dorsal raphe nucleus publication-title: Brain Res – volume: 108 start-page: 387 year: 1992 end-page: 389 ident: bib137 article-title: Slow wave sleep and 5-HT2 receptor sensitivity in generalized anxiety disorder publication-title: Pschopharmacology – volume: 39 start-page: 123 year: 2000 end-page: 132 ident: bib54 article-title: Immunohistochemical localization of the 5-HT publication-title: Neuropharmacology – volume: 34 start-page: 1635 year: 1995 end-page: 1645 ident: bib52 article-title: Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera publication-title: Neuropharmacology – volume: 19 start-page: 3204 year: 1999 end-page: 3212 ident: bib87 article-title: Key role of 5-HT publication-title: J Neurosci – start-page: 457 year: 2008 end-page: 475 ident: bib150 article-title: Sleep and waking in mutant mice that do not express various proteins involved in serotonergic neurotransmission such as the serotonergic transporter, monoamine oxidase A, and 5-HT publication-title: Serotonin and sleep: molecular, functional and clinical aspects – start-page: 31 year: 2001 end-page: 43 ident: bib151 article-title: Mechanisms of drug action and the relationship between drug concentration and effect publication-title: The pharmacological basis of therapeutics – volume: 30 start-page: 1189 year: 2006 ident: 10.1016/j.smrv.2010.11.003_bib95 article-title: Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2006.02.013 – volume: 101 start-page: 568 year: 1990 ident: 10.1016/j.smrv.2010.11.003_bib119 article-title: Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans publication-title: Psychopharmacology doi: 10.1007/BF02244239 – volume: 51 start-page: 158 year: 2003 ident: 10.1016/j.smrv.2010.11.003_bib131 article-title: 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex publication-title: Synapse doi: 10.1002/syn.10288 – start-page: 17 year: 2002 ident: 10.1016/j.smrv.2010.11.003_bib24 article-title: Neurotransmitters and neuromodulators regulating sleep – volume: 97 start-page: 436 year: 1989 ident: 10.1016/j.smrv.2010.11.003_bib99 article-title: Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat publication-title: Psychopharmacology doi: 10.1007/BF00439544 – volume: 365 start-page: 200 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib145 article-title: GABA en pedunculopontine tegmentum regulates spontaneous rapid eye movement sleep by acting on GABAA receptors in freely moving rats publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.04.080 – volume: 22 start-page: 4686 year: 2002 ident: 10.1016/j.smrv.2010.11.003_bib69 article-title: Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-11-04686.2002 – volume: 31 start-page: 34 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib105 article-title: Selective 5-HT2A and 5-HT6 antagonists promote sleep in the rat publication-title: Sleep doi: 10.1093/sleep/31.1.34 – volume: 101 start-page: 569 year: 1976 ident: 10.1016/j.smrv.2010.11.003_bib67 article-title: Dorsal raphe neurons: depression of firing during sleep publication-title: Brain Res doi: 10.1016/0006-8993(76)90480-7 – volume: 58 start-page: 831 year: 2005 ident: 10.1016/j.smrv.2010.11.003_bib132 article-title: 5-HT7 inhibition and inactivation induce antidepressantlike behavior and sleep pattern publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.05.012 – volume: 888 start-page: 51 year: 2001 ident: 10.1016/j.smrv.2010.11.003_bib113 article-title: M100,907, a selective 5-HT(2A) antagonist attenuates dopamine release in the rat medial prefrontal cortex publication-title: Brain Res doi: 10.1016/S0006-8993(00)03004-3 – volume: 118 start-page: 109 year: 1980 ident: 10.1016/j.smrv.2010.11.003_bib9 article-title: Inversion de l'insomnie produit par la chlorophenylalanine chez le chat publication-title: Arch Ital Biol – volume: 33 start-page: 467 year: 1994 ident: 10.1016/j.smrv.2010.11.003_bib118 article-title: Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors publication-title: Neuropharmacology doi: 10.1016/0028-3908(94)90077-9 – volume: 330 start-page: 543 year: 1993 ident: 10.1016/j.smrv.2010.11.003_bib34 article-title: Aminergic and cholinergic afferents to REM sleep induction regions of the pontine reticular formation in the rat publication-title: J Comp Neurol doi: 10.1002/cne.903300410 – volume: 51 start-page: 353 year: 1995 ident: 10.1016/j.smrv.2010.11.003_bib102 article-title: Effects of sertindole on sleep–wake states, electroencephalogram, behavioral patterns, and epileptic activity in rats publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(94)00394-X – volume: 8 start-page: 75 year: 2005 ident: 10.1016/j.smrv.2010.11.003_bib86 article-title: A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145704004511 – volume: 128 start-page: 583 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib21 article-title: 5-hydroxytryptamine1A-like receptor activation in the bed nucleus of the stria terminalis: electrophysiological and behavioral studies publication-title: Neuroscience doi: 10.1016/j.neuroscience.2004.06.037 – volume: 16 start-page: 2820 year: 1996 ident: 10.1016/j.smrv.2010.11.003_bib70 article-title: Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) into the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving rat publication-title: J Neurosci doi: 10.1523/JNEUROSCI.16-08-02820.1996 – volume: 216 start-page: 381 year: 2011 ident: 10.1016/j.smrv.2010.11.003_bib107 article-title: Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT2A receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light–dark cycle publication-title: Behav Brain Res doi: 10.1016/j.bbr.2010.08.020 – volume: 1265 start-page: 103 year: 2009 ident: 10.1016/j.smrv.2010.11.003_bib26 article-title: Effects on sleep of melanin-concentrating hormone (MCH) microinjections into the dorsal raphe nucleus publication-title: Brain Res doi: 10.1016/j.brainres.2009.02.010 – volume: 53 start-page: 202 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib114 article-title: Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat publication-title: Synapse doi: 10.1002/syn.20054 – volume: 31 start-page: 239 year: 1972 ident: 10.1016/j.smrv.2010.11.003_bib14 article-title: Sleep changes during chronic administration of parachlorophenylalanine publication-title: Can J Biol – volume: 10 start-page: 204 year: 1967 ident: 10.1016/j.smrv.2010.11.003_bib10 article-title: The effects of p-chlorophenylalanine, a serotonin depletor on avoidance adquisition, pain sensitivity and related behavior in the rat publication-title: Psychopharmacology doi: 10.1007/BF00401382 – volume: 45 start-page: 203 year: 1998 ident: 10.1016/j.smrv.2010.11.003_bib122 article-title: Feedback stimulation of somatodendritic serotonin release: a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat publication-title: Brain Res Bull doi: 10.1016/S0361-9230(97)00340-7 – volume: 18 start-page: 1041 year: 2003 ident: 10.1016/j.smrv.2010.11.003_bib27 article-title: Interleukin1β enhances non-rapid eye movement sleep when microinjected into the dorsal raphe nucleus and inhibits serotonergic neurons in vitro publication-title: Eur J Neurosci doi: 10.1046/j.1460-9568.2003.02836.x – volume: 934 start-page: 49 year: 2002 ident: 10.1016/j.smrv.2010.11.003_bib61 article-title: The distribution of 5-HT6 receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist [125I]SB-258585 publication-title: Brain Res doi: 10.1016/S0006-8993(02)02360-0 – volume: 1 start-page: 169 year: 1992 ident: 10.1016/j.smrv.2010.11.003_bib75 article-title: Dose-dependent effects of the 5-HT1A receptor agonist 8-OHDPAT on sleep and wakefulness in the rat publication-title: J Sleep Res doi: 10.1111/j.1365-2869.1992.tb00033.x – volume: 166 start-page: 1433 year: 1969 ident: 10.1016/j.smrv.2010.11.003_bib11 article-title: Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized male rats publication-title: Science doi: 10.1126/science.166.3911.1433 – volume: 104 start-page: 1141 year: 2001 ident: 10.1016/j.smrv.2010.11.003_bib68 article-title: Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake–sleep states publication-title: Neuroscience doi: 10.1016/S0306-4522(01)00103-8 – volume: 99 start-page: 219 year: 1989 ident: 10.1016/j.smrv.2010.11.003_bib134 article-title: Effects of repeated ritanserin on middle-aged poor sleepers publication-title: Psychopharmacology doi: 10.1007/BF00442811 – volume: 148 start-page: 1213 year: 1991 ident: 10.1016/j.smrv.2010.11.003_bib81 article-title: Buspirone: sedative or stimulant effect? publication-title: Am J Psychiatry doi: 10.1176/ajp.148.9.1213 – start-page: 25 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib44 article-title: Topographic organization and chemoarchitecture of the dorsal raphe nucleus and the median raphe nucleus – volume: 21 start-page: 9856 year: 2001 ident: 10.1016/j.smrv.2010.11.003_bib97 article-title: Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-24-09856.2001 – volume: 95 start-page: 1597 year: 2005 ident: 10.1016/j.smrv.2010.11.003_bib115 article-title: The activation of 5-HT2A receptors in prefrontal cortex enhances dopaminergic activity publication-title: J Neurochem doi: 10.1111/j.1471-4159.2005.03485.x – volume: 129 start-page: 64P year: 2000 ident: 10.1016/j.smrv.2010.11.003_bib130 article-title: Reversal of a scopolamine-induced deficit in object discrimination by a selective 5-HT6 receptor antagonist, RO-046790, in rats publication-title: Br J Pharmacol – volume: 31 start-page: 131 year: 1973 ident: 10.1016/j.smrv.2010.11.003_bib13 article-title: Physiological and behavioral effects of parachlorophenylalanine in the rat publication-title: Psychopharmacology doi: 10.1007/BF00419813 – volume: 86 start-page: 133 year: 1992 ident: 10.1016/j.smrv.2010.11.003_bib139 article-title: 5-HT2 receptor antagonism and slow wave sleep in major depression publication-title: Acta Psychiatr Scand doi: 10.1111/j.1600-0447.1992.tb03241.x – volume: 142 start-page: 369 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib149 article-title: Contribution of the “knock-out” technology to understanding the role of serotonin in sleep regulations publication-title: Ach Ital Biol – volume: 16 start-page: 647 year: 1993 ident: 10.1016/j.smrv.2010.11.003_bib136 article-title: The effects of ritanserin on mood and sleep in abstinent alcoholic patients publication-title: Sleep doi: 10.1093/sleep/16.7.647 – volume: 33 start-page: 467 year: 2002 ident: 10.1016/j.smrv.2010.11.003_bib109 article-title: Effect of SB-243213, a selective 5-HT2C receptor antagonist on the rat sleep profile: a comparison to paroxetine publication-title: Pharmacol Biochem Behav – volume: 165 start-page: 1390 year: 2010 ident: 10.1016/j.smrv.2010.11.003_bib49 article-title: Presynaptic 5-HT1B receptor-mediated serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis publication-title: Neuroscience doi: 10.1016/j.neuroscience.2009.11.071 – volume: 402 start-page: 385 year: 1998 ident: 10.1016/j.smrv.2010.11.003_bib58 article-title: Distribution of neurons expressing immunoreactivity for the 5-HT3 receptor subtype in the rat brain and spinal cord publication-title: J Comp Neurol doi: 10.1002/(SICI)1096-9861(19981221)402:3<385::AID-CNE7>3.0.CO;2-Q – volume: 163 start-page: 135 year: 1979 ident: 10.1016/j.smrv.2010.11.003_bib3 article-title: Raphe unit activity in freely moving cats: correlation with level of behavioral arousal publication-title: Brain Res doi: 10.1016/0006-8993(79)90157-4 – volume: 5 start-page: 541 year: 1993 ident: 10.1016/j.smrv.2010.11.003_bib20 article-title: Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.1993.tb00519.x – volume: 10 start-page: 2771 year: 1992 ident: 10.1016/j.smrv.2010.11.003_bib59 article-title: Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands publication-title: Synapse doi: 10.1002/syn.890100402 – volume: 122 start-page: 193 year: 2003 ident: 10.1016/j.smrv.2010.11.003_bib66 article-title: Neurochemical and anatomical identification of fast- and slow-firing neurons in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo publication-title: Neuroscience doi: 10.1016/S0306-4522(03)00518-9 – volume: 42 start-page: 69 year: 2000 ident: 10.1016/j.smrv.2010.11.003_bib85 article-title: Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality publication-title: Neuropsychobiology doi: 10.1159/000026676 – volume: 624 start-page: 188 year: 1993 ident: 10.1016/j.smrv.2010.11.003_bib35 article-title: Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens publication-title: Brain Res doi: 10.1016/0006-8993(93)90077-Z – volume: 12 start-page: 47 year: 2002 ident: 10.1016/j.smrv.2010.11.003_bib71 article-title: Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OH-DPAT: prevention with WAY 100635 publication-title: Eur Neuropsychopharmacol doi: 10.1016/S0924-977X(01)00133-X – year: 1996 ident: 10.1016/j.smrv.2010.11.003_bib37 – volume: 3 start-page: 59 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib62 article-title: 5-HT6 receptors publication-title: Curr Drug Targets CNS Neurol Disord doi: 10.2174/1568007043482561 – volume: 9 start-page: 3251 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib120 article-title: Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders publication-title: Expert Opin Pharmacother doi: 10.1517/14656560802532707 – volume: 115 start-page: 273 year: 1994 ident: 10.1016/j.smrv.2010.11.003_bib77 article-title: Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat publication-title: Psychopharmacology doi: 10.1007/BF02244783 – volume: vol. 3 start-page: 68 year: 1984 ident: 10.1016/j.smrv.2010.11.003_bib142 article-title: Serotonin-immunoreactive neurons and their projections in the CNS – volume: 39 start-page: 123 year: 2000 ident: 10.1016/j.smrv.2010.11.003_bib54 article-title: Immunohistochemical localization of the 5-HT2C receptor protein in the rat CNS publication-title: Neuropharmacology doi: 10.1016/S0028-3908(99)00086-6 – volume: 468 start-page: 518 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib36 article-title: Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and association with serotonin and gamma-aminobutyric acid neurons publication-title: J Comp Neurol doi: 10.1002/cne.10976 – volume: 40 start-page: 399 year: 1991 ident: 10.1016/j.smrv.2010.11.003_bib147 article-title: 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex publication-title: Neuroscience doi: 10.1016/0306-4522(91)90128-B – volume: 5 start-page: 145 year: 1982 ident: 10.1016/j.smrv.2010.11.003_bib15 article-title: Sleep regulation after reduction of brain serotonin: effect of p-chlorophenylalanine combined with sleep deprivation in the rat publication-title: Sleep doi: 10.1093/sleep/5.2.145 – volume: 26 start-page: 1862 year: 2007 ident: 10.1016/j.smrv.2010.11.003_bib28 article-title: Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2007.05796.x – volume: 95 start-page: 445 year: 2000 ident: 10.1016/j.smrv.2010.11.003_bib17 article-title: 5-Hydroxytryptophan, but not l-tryptophan, alters sleep and brain temperature in rats publication-title: Neuroscience doi: 10.1016/S0306-4522(99)00435-2 – volume: 478 start-page: 121 year: 2003 ident: 10.1016/j.smrv.2010.11.003_bib74 article-title: Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2003.08.039 – volume: 25 start-page: 11231 year: 2005 ident: 10.1016/j.smrv.2010.11.003_bib93 article-title: Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1724-05.2005 – volume: 382 start-page: 302 year: 1997 ident: 10.1016/j.smrv.2010.11.003_bib33 article-title: Serotonergic dorsal raphe nucleus projections to the cholinergic and noncholinergic neurons of the pedunculopontine tegmental region: a light and electron microscopic anterograde tracing and immunohistochemical study publication-title: J Comp Neurol doi: 10.1002/(SICI)1096-9861(19970609)382:3<302::AID-CNE2>3.0.CO;2-7 – volume: 963 start-page: 57 year: 2003 ident: 10.1016/j.smrv.2010.11.003_bib123 article-title: Glutamatergic afferent projections to the dorsal raphe nucleus of the rat publication-title: Brain Res doi: 10.1016/S0006-8993(02)03841-6 – volume: vol 85 start-page: 13 year: 1990 ident: 10.1016/j.smrv.2010.11.003_bib146 article-title: Neurotransmitters in the cerebral cortex – volume: 34 start-page: 1647 year: 1995 ident: 10.1016/j.smrv.2010.11.003_bib91 article-title: Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat publication-title: Neuropharmacology doi: 10.1016/0028-3908(95)00112-3 – volume: 553 start-page: 149 year: 1991 ident: 10.1016/j.smrv.2010.11.003_bib57 article-title: Localization of 5-HT3 receptors in the rat using [3H]LY278584 publication-title: Brain Res doi: 10.1016/0006-8993(91)90242-N – volume: 289 start-page: 1009 year: 1983 ident: 10.1016/j.smrv.2010.11.003_bib65 article-title: Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices publication-title: Brain Res doi: 10.1016/0006-8993(83)90011-2 – start-page: 31 year: 2001 ident: 10.1016/j.smrv.2010.11.003_bib151 article-title: Mechanisms of drug action and the relationship between drug concentration and effect – volume: 24 start-page: 3415 year: 2006 ident: 10.1016/j.smrv.2010.11.003_bib89 article-title: Selective 5-HT1B receptor inhibition of glutamatergic and gabaergic synaptic activity in the rat dorsal and median raphe publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2006.05222.x – volume: 409 start-page: 187 year: 1999 ident: 10.1016/j.smrv.2010.11.003_bib53 article-title: Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of the adult rat publication-title: J Comp Neurol doi: 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P – volume: 27 start-page: 869 year: 2002 ident: 10.1016/j.smrv.2010.11.003_bib92 article-title: Sleep and sleep homeostasis in mice lacking the 5-HT2C receptor publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(02)00353-6 – volume: 897 start-page: 122 year: 2001 ident: 10.1016/j.smrv.2010.11.003_bib72 article-title: Sleep and waking following microdialysis perfusion of the selective 5-HT1A antagonist p-MPPI into the dorsal raphe nucleus of the freely moving rat publication-title: Brain Res doi: 10.1016/S0006-8993(01)02101-1 – volume: 72 start-page: 165 year: 1992 ident: 10.1016/j.smrv.2010.11.003_bib40 article-title: Structure and function of the brain serotonin system publication-title: Physiol Rev doi: 10.1152/physrev.1992.72.1.165 – volume: 54 start-page: 409 year: 1993 ident: 10.1016/j.smrv.2010.11.003_bib112 article-title: 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons publication-title: Neuroscience doi: 10.1016/0306-4522(93)90262-E – volume: 108 start-page: 387 year: 1992 ident: 10.1016/j.smrv.2010.11.003_bib137 article-title: Slow wave sleep and 5-HT2 receptor sensitivity in generalized anxiety disorder publication-title: Pschopharmacology doi: 10.1007/BF02245128 – volume: 46 start-page: 697 year: 1996 ident: 10.1016/j.smrv.2010.11.003_bib47 article-title: Ultrastructural localization of 5 -hydroxytryptamine1A receptors in the rat brain publication-title: J Neurosci Res doi: 10.1002/(SICI)1097-4547(19961215)46:6<697::AID-JNR7>3.0.CO;2-A – volume: 278 start-page: 111 year: 1995 ident: 10.1016/j.smrv.2010.11.003_bib127 article-title: Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(95)00108-W – start-page: 187 year: 2001 ident: 10.1016/j.smrv.2010.11.003_bib38 article-title: 5-Hydroxytryptamine – volume: 944 start-page: 1 year: 2002 ident: 10.1016/j.smrv.2010.11.003_bib144 article-title: GABAergic mechanisms in the pedunculopontine tegmental nucleus of the cat promote active (REM) sleep publication-title: Brain Res doi: 10.1016/S0006-8993(02)02475-7 – volume: 7 start-page: 145 year: 1990 ident: 10.1016/j.smrv.2010.11.003_bib76 article-title: 5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 8-OH-DPAT increase wakefulness in the rat publication-title: Biogen Amines – volume: 59 start-page: 360 year: 2007 ident: 10.1016/j.smrv.2010.11.003_bib94 article-title: 5-HT receptor regulation of neurotransmitter release publication-title: Pharmacol Rev doi: 10.1124/pr.59.07103 – volume: 58 start-page: 249 year: 1999 ident: 10.1016/j.smrv.2010.11.003_bib148 article-title: The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(98)00084-7 – volume: 996 start-page: 9 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib98 article-title: A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement occurrence in the rat publication-title: Brain Res doi: 10.1016/j.brainres.2003.09.026 – volume: 117 start-page: 657 year: 1996 ident: 10.1016/j.smrv.2010.11.003_bib63 article-title: A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-HT7 receptor in rat brain publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1996.tb15241.x – volume: 114 start-page: 517 year: 1976 ident: 10.1016/j.smrv.2010.11.003_bib6 article-title: Depletion of brain 5-HT following intraventricular 5,7-dihydroxytryptamine fails to disrupt sleep in the rat publication-title: Brain Res doi: 10.1016/0006-8993(76)90975-6 – volume: 474 start-page: 464 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib46 article-title: Differential expression of 5-HT1A, alpha(1B) adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus publication-title: J Comp Neurol doi: 10.1002/cne.20138 – volume: 115 start-page: 622 year: 1995 ident: 10.1016/j.smrv.2010.11.003_bib55 article-title: The pharmacology and distribution of human 5-hydroxytryptamine(2B) (5-HT2B) receptor gene products – comparison with 5.HT2A and 5-HT2C receptors publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1995.tb14977.x – volume: 9 start-page: 248 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib1 article-title: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision publication-title: World J Biol Psychiatry doi: 10.1080/15622970802465807 – volume: 286 start-page: 913 year: 1998 ident: 10.1016/j.smrv.2010.11.003_bib108 article-title: 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)37669-4 – volume: 378 start-page: 164 year: 1986 ident: 10.1016/j.smrv.2010.11.003_bib116 article-title: 5-Hydroxytryptamine-2 antagonist ritanserin increases human slow wave sleep publication-title: Brain Res doi: 10.1016/0006-8993(86)90299-4 – volume: 64 start-page: 166 year: 1972 ident: 10.1016/j.smrv.2010.11.003_bib2 article-title: The role of monoamines and acetylcholine containing neurons in the regulation of the sleep–waking cycle publication-title: Ergeb Physiol – volume: 124 start-page: 79 year: 2010 ident: 10.1016/j.smrv.2010.11.003_bib143 article-title: Increased GABAergic activity in the region of the pedunculopontine and deep mesencephalic reticular nuclei reduces REM sleep and impairs learning in rats publication-title: Behav Neurosci doi: 10.1037/a0018244 – volume: 88 start-page: 899 year: 1999 ident: 10.1016/j.smrv.2010.11.003_bib51 article-title: Cellular and subcellullar localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies publication-title: Neuroscience doi: 10.1016/S0306-4522(98)00256-5 – volume: 315 start-page: 921 year: 2005 ident: 10.1016/j.smrv.2010.11.003_bib110 article-title: Despite similar anxiolytic potential, the 5-hydroxytryptamine2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.105.086413 – volume: 164 start-page: 1776 year: 2009 ident: 10.1016/j.smrv.2010.11.003_bib56 article-title: Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes publication-title: Neuroscience doi: 10.1016/j.neuroscience.2009.09.028 – volume: 93 start-page: 257 year: 1998 ident: 10.1016/j.smrv.2010.11.003_bib103 article-title: Age-dependent effect of ketanserin on the sleep–waking phases in rats publication-title: Int J Neurosci doi: 10.3109/00207459808986431 – volume: 289 start-page: R1116 year: 2005 ident: 10.1016/j.smrv.2010.11.003_bib18 article-title: Antagonism of corticotropin-releasing hormone alters serotonergic-induced changes in brain temperature, but not sleep, of rats publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00074.2005 – volume: 332 start-page: 281 year: 2010 ident: 10.1016/j.smrv.2010.11.003_bib106 article-title: Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.109.160994 – volume: 130 start-page: 23 year: 2000 ident: 10.1016/j.smrv.2010.11.003_bib129 article-title: In vivo effects of the 5-HT6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0703288 – start-page: 69 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib39 article-title: Efferent and afferent connections of the dorsal and median raphe nuclei in the rat – volume: 199 start-page: 349 year: 1991 ident: 10.1016/j.smrv.2010.11.003_bib96 article-title: Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(91)90499-G – volume: 116 start-page: 433 year: 1994 ident: 10.1016/j.smrv.2010.11.003_bib82 article-title: Inhibition of REM sleep by ipsapirone, a 5-HT1A agonist, in normal volunteers publication-title: Psychopharmacology doi: 10.1007/BF02247474 – volume: 49 start-page: 93 year: 1994 ident: 10.1016/j.smrv.2010.11.003_bib73 article-title: Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(94)90461-8 – volume: 87 start-page: 371 year: 1985 ident: 10.1016/j.smrv.2010.11.003_bib80 article-title: Buspirone: and anxiolytic without sedative effect publication-title: Psychopharmacology doi: 10.1007/BF00432724 – volume: 9 start-page: R1 year: 1998 ident: 10.1016/j.smrv.2010.11.003_bib32 article-title: The neuropsychology of REM sleep dreaming publication-title: Neuroreport doi: 10.1097/00001756-199802160-00033 – volume: 364 start-page: 89 year: 1999 ident: 10.1016/j.smrv.2010.11.003_bib128 article-title: Effects of accumbens m-chlorophenylbiguanide microinjection on sleep and waking in intact and 6-hydroxydopamine-treated rats publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(98)00826-7 – volume: 19 start-page: 72 year: 1989 ident: 10.1016/j.smrv.2010.11.003_bib135 article-title: Polysomnographic effects of ritanserin in insomniacs. A crossed double-blind controlled study publication-title: Sleep Res – volume: 96 start-page: 395 year: 1988 ident: 10.1016/j.smrv.2010.11.003_bib138 article-title: Effect of ritanserin on sleep disturbances in dysthymic patients publication-title: Psychopharmacology doi: 10.1007/BF00216069 – volume: 142 start-page: 1332 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib111 article-title: Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0705887 – volume: 140 start-page: 389 year: 1984 ident: 10.1016/j.smrv.2010.11.003_bib16 article-title: Neuromediateurs et facteurs hypnogènes publication-title: Rev Neurol – volume: 5 start-page: 17 year: 1968 ident: 10.1016/j.smrv.2010.11.003_bib8 article-title: Insomnia following parachlorophenylalanine in the rat publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(68)90151-9 – volume: 8 start-page: 291 year: 2007 ident: 10.1016/j.smrv.2010.11.003_bib25 article-title: Hypothalamic control of sleep publication-title: Sleep Med doi: 10.1016/j.sleep.2007.03.013 – volume: 26 start-page: 615 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib124 article-title: Activation of presynaptic 5-HT3 receptors facilitates glutamatergic synaptic inputs to area postrema neurons in rat brain slices publication-title: Methods Find Exp Clin Pharmacol doi: 10.1358/mf.2004.26.8.863726 – volume: 34 start-page: 1635 year: 1995 ident: 10.1016/j.smrv.2010.11.003_bib52 article-title: Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera publication-title: Neuropharmacology doi: 10.1016/0028-3908(95)00138-7 – volume: 33 start-page: 1309 year: 2009 ident: 10.1016/j.smrv.2010.11.003_bib64 article-title: The response of neurons of the bed nucleus of the stria terminalis to serotonin: implications for anxiety publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2009.05.013 – start-page: 1859 year: 2002 ident: 10.1016/j.smrv.2010.11.003_bib22 article-title: Basic mechanisms of sleep: New evidence on the neuroanatomy and neuromodulation of the NREM–REM cycle – volume: 39 start-page: 279 year: 1990 ident: 10.1016/j.smrv.2010.11.003_bib30 article-title: A cholinoceptive desynchronized sleep induction zone in the anterodorsal pontine tegmentum: locus of the sensitive region publication-title: Neuroscience doi: 10.1016/0306-4522(90)90267-8 – volume: 191 start-page: 184 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib133 article-title: The serotonin 5-HT7 agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat publication-title: Behav Brain Res doi: 10.1016/j.bbr.2008.03.025 – volume: 19 start-page: 3204 year: 1999 ident: 10.1016/j.smrv.2010.11.003_bib87 article-title: Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.19-08-03204.1999 – volume: 193 start-page: 268 year: 1993 ident: 10.1016/j.smrv.2010.11.003_bib60 article-title: A novel rat serotonin (5-HT6) receptor - molecular cloning, localization and stimulation of cAMP accumulation publication-title: Biochem Biophys Res Comm doi: 10.1006/bbrc.1993.1619 – volume: 249 start-page: 259 year: 1993 ident: 10.1016/j.smrv.2010.11.003_bib125 article-title: The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(93)90520-R – start-page: 401 year: 1973 ident: 10.1016/j.smrv.2010.11.003_bib5 article-title: The effect of para-chlorophenylalanine in the rat: some implications for the serotonin-sleep hypothesis – volume: 137 start-page: 145 year: 1987 ident: 10.1016/j.smrv.2010.11.003_bib100 article-title: 5-HT2 receptors could be primarily involved in the regulation of slow wave sleep in the rat publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(87)90196-8 – volume: 52 start-page: 305 year: 1995 ident: 10.1016/j.smrv.2010.11.003_bib79 article-title: Sleep and waking in 5,7-DHT-lesioned or (−)pindolol-pretreated rats after administration of buspirone, ipsapirone or gepirone publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(94)00414-E – volume: 31 start-page: 519 year: 1992 ident: 10.1016/j.smrv.2010.11.003_bib126 article-title: Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat publication-title: Neuropharmacology doi: 10.1016/0028-3908(92)90183-P – volume: 27 start-page: 529 year: 1969 ident: 10.1016/j.smrv.2010.11.003_bib4 article-title: Effects of para-chlorophenylalanine on sleep in man publication-title: Electroencephalogr Clin Neurophysiol doi: 10.1016/0013-4694(69)90193-X – volume: 498 start-page: 611 year: 2006 ident: 10.1016/j.smrv.2010.11.003_bib48 article-title: Quantitative mapping of tryptophan hydroxylase-2, 5-HT1A, 5-HT1B and serotonin transporter expression across the anteroposterior axis of the rat dorsal and median raphe nuclei publication-title: J Comp Neurol doi: 10.1002/cne.21073 – start-page: 457 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib150 article-title: Sleep and waking in mutant mice that do not express various proteins involved in serotonergic neurotransmission such as the serotonergic transporter, monoamine oxidase A, and 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C and 5-HT7 receptors – volume: 553 start-page: 163 year: 2006 ident: 10.1016/j.smrv.2010.11.003_bib104 article-title: Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A and 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2006.09.027 – volume: 31 start-page: 21 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib19 article-title: Effects of serotonergic activation by5-hydroxytryptophan on sleep and body temperature of C57BL/6J and interleukin-6-deficient mice are dose and time related publication-title: Sleep doi: 10.1093/sleep/31.1.21 – volume: 900 start-page: 110 year: 2001 ident: 10.1016/j.smrv.2010.11.003_bib42 article-title: Morphological features and electrophysiological properties of serotonergic and non-serotonergic projection neurons in the dorsal raphe nucleus publication-title: Brain Res doi: 10.1016/S0006-8993(01)02272-7 – start-page: 155 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib45 article-title: Molecular biology of 5-HT receptors – volume: 5 start-page: 63 year: 2001 ident: 10.1016/j.smrv.2010.11.003_bib31 article-title: Brain structures and mechanisms involved in the generation of REM sleep publication-title: Sleep Med Rev doi: 10.1053/smrv.2000.0136 – volume: 32 start-page: 9407 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib121 article-title: Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2007.12.024 – volume: 206 start-page: 8 year: 2010 ident: 10.1016/j.smrv.2010.11.003_bib88 article-title: Activation of serotonin 5-HT1B receptor in the dorsal raphe nucleus affects REM sleep in the rat publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.08.037 – start-page: 197 year: 1989 ident: 10.1016/j.smrv.2010.11.003_bib117 article-title: The effects of ritanserin and seganserin on human slow wave sleep – volume: 8 start-page: 438 year: 2003 ident: 10.1016/j.smrv.2010.11.003_bib23 article-title: Arousal systems publication-title: Front Biosci doi: 10.2741/1074 – volume: 29 start-page: 1795 year: 2009 ident: 10.1016/j.smrv.2010.11.003_bib141 article-title: Antagonist of serotonergic 5-HT2A/2C receptors: mutual improvement of sleep, cognition and mood publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2009.06718.x – volume: 3 start-page: 83 year: 1978 ident: 10.1016/j.smrv.2010.11.003_bib7 article-title: Effects of chronic tryptophan dietary deficiency on the rat’s sleep-wake cycle publication-title: Brain Res Bull doi: 10.1016/0361-9230(78)90064-3 – volume: 10 start-page: 22 issue: Suppl. 1 year: 1996 ident: 10.1016/j.smrv.2010.11.003_bib83 article-title: Effects of antidepressant treatment on sleep EEG in depression publication-title: J Psychopharmacol doi: 10.1177/026988119601001s01 – volume: 15 start-page: 524 year: 1969 ident: 10.1016/j.smrv.2010.11.003_bib12 article-title: The effects of p-chlorophenylalanine on behavior in rats: relation to brain serotonin and 5-hydroxyindolacetic acid publication-title: Brain Res doi: 10.1016/0006-8993(69)90175-9 – volume: 485 start-page: 294 year: 1989 ident: 10.1016/j.smrv.2010.11.003_bib101 article-title: Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats publication-title: Brain Res doi: 10.1016/0006-8993(89)90573-8 – volume: 127 start-page: 133 year: 1989 ident: 10.1016/j.smrv.2010.11.003_bib29 article-title: Mapping of cholinoceptive brainstem structures responsible for the generation of paradoxical sleep in the cat publication-title: Arch Ital Biol – volume: 11 start-page: 49 year: 1999 ident: 10.1016/j.smrv.2010.11.003_bib84 article-title: Effects of antidepressant drugs on sleep EEG in patients with major depression publication-title: Cent Nerv Syst Drugs – volume: 72 start-page: 64 year: 1986 ident: 10.1016/j.smrv.2010.11.003_bib78 article-title: The effect of buspirone on sleep in the rat publication-title: Neurosci Lett doi: 10.1016/0304-3940(86)90619-1 – volume: 31 start-page: 1663 year: 2008 ident: 10.1016/j.smrv.2010.11.003_bib140 article-title: APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia publication-title: Sleep doi: 10.1093/sleep/31.12.1663 – volume: 1018 start-page: 46 year: 2004 ident: 10.1016/j.smrv.2010.11.003_bib43 article-title: Anatomic and functional topography of the dorsal raphe nucleus publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1296.005 – volume: 33 start-page: 367 year: 1994 ident: 10.1016/j.smrv.2010.11.003_bib50 article-title: Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger mRNA in rodent and primate brain publication-title: Neuropharmacology doi: 10.1016/0028-3908(94)90067-1 – volume: 3 start-page: 97 year: 1994 ident: 10.1016/j.smrv.2010.11.003_bib90 article-title: Effects of the selective 5-HT1B agonist CGS 12066B, on sleep/waking stages and EEG power spectrum in rats publication-title: J Sleep Res doi: 10.1111/j.1365-2869.1994.tb00112.x – volume: 15 start-page: 111 year: 1998 ident: 10.1016/j.smrv.2010.11.003_bib41 article-title: Chemoarchitecture of the primate dorsal raphe nucleus publication-title: J Chem Neuroanat doi: 10.1016/S0891-0618(98)00036-2 |
| SSID | ssj0009416 |
| Score | 2.5116217 |
| SecondaryResourceType | review_article |
| Snippet | Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions... Summary Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that serotonin (5-HT) functions... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 269 |
| SubjectTerms | 5-HT receptors Animals Basal forebrain Brain - physiology Brain stem Dorsal raphe nucleus Humans Laterodorsal and pedunculopontine tegmental nuclei Mice Neurology Raphe Nuclei - physiology Rapid eye movement sleep Rats Receptors, Serotonin - physiology Serotonin Serotonin - physiology Sleep Sleep - physiology Sleep Medicine Sleep Wake Disorders - physiopathology Sleep, REM - physiology Slow wave sleep Wakefulness Wakefulness - physiology |
| Title | Serotonin control of sleep-wake behavior |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1087079210001334 https://www.clinicalkey.es/playcontent/1-s2.0-S1087079210001334 https://dx.doi.org/10.1016/j.smrv.2010.11.003 https://www.ncbi.nlm.nih.gov/pubmed/21459634 https://www.proquest.com/docview/872524962 |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB6KXgQR39ZHycGDILHJJpvHsRRLfRVRC70tu8kEqrUtTas3f7u7yW5FqhU8BcIOSSYz387uznwDcCphV1DOhS0Ch9t-RqgdO1w6nvCECF2a8eIo5q4TtLv-dY_2KtA0tTAqrVJjf4npBVrrO3Wtzfq4368_uk6k6N2IW8QxnuIE9f1QWfnFx1eaR-wX7U_VYFuN1oUzZY5X_jp5K9O7FJOnaZy1ODn9FnwWk1BrEzZ09Gg1yhfcggoOt2G93HqzyoqiHTiT_j-aqm1WSyeiW6PMygeIY_udv6BlSvN3odu6fGq2bd0QwU78wJ3amHIkCSFCZDFSkmCIKfFSOY0LLyFZJAIZL8eRoEmcoYQyLNhvMo5IgzgL0NuDleFoiAdg-SlRhytcoFwjpQEKqZ8kikOCFF3B4yq4RhMs0WzhqmnFgJm0sGemtMeU9uQyQnGMVuF8LjMuuTKWjvaMgpmpApW4xSSUL5UKf5LCXLtezlyWE-awBfOoAp1LfrOwP59omb_PpOup8xQ-xNEsZ1FIqFy9BqQK-6VVzD9b8b9LaPMP__nQI1gzm9eOewwr08kMT2T0MxW1wrxrsNpoPtzeq-vVTbvzCVYMBC0 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLbGdgAJId6MZw8ckFC1Nm36OE4TaGNjFzaJW5S0rgSMbVo3-PskbTKExkPiWsVK6zpfnNj-DHApYVdQzoUtAofbfkaoHTtcLjzhCRG6NONFKOa-H7SH_t0jfaxAy9TCqLRKjf0lphdorZ80tDYb06enxoPrRIrejbiFH-P5a1BT7FS0CrVmp9vuf3Lv-kUHVDXeVgK6dqZM88pfZ29lhpci8zS9s1b3p5_8z2Ifut2GLe1AWs3yHXegguNd2Cxv36yyqGgPriQETObqptXSuejWJLPyEeLUfucvaJnq_H0Y3t4MWm1b90SwEz9w5zamHElCiBBZjJQkGGJKvFTu5MJLSBaJQLrMcSRoEmco0QwLApyMI9IgzgL0DqA6nozxCCw_JSq-wgXKY1IaoJD6SaI4JEjRFTyug2s0wRJNGK76VoyYyQx7Zkp7TGlPniQUzWgdrpcy05Iu49fRnlEwM4WgErqYRPNfpcLvpDDXqy9nLssJc9iKhdSBLiW_GNmfM1rm7zO5-lRIhY9xsshZFBIqD7ABqcNhaRXLz1YU8BLd_ON_TnoB6-3BfY_1Ov3uCWyYu2zHPYXqfLbAM-kMzcW5NvYPFx8FSQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serotonin+control+of+sleep-wake+behavior&rft.jtitle=Sleep+medicine+reviews&rft.au=Monti%2C+Jaime+M&rft.date=2011-08-01&rft.issn=1087-0792&rft.volume=15&rft.issue=4&rft.spage=269&rft.epage=281&rft_id=info:doi/10.1016%2Fj.smrv.2010.11.003&rft.externalDBID=ECK1-s2.0-S1087079210001334&rft.externalDocID=1_s2_0_S1087079210001334 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10870792%2FS1087079211X00047%2Fcov150h.gif |